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Abstract 
The sulfur containing vitamin, biotin has a cofactorial role for a number of 
carboxylation enzymes responsible for a variety of essential metabolic processes. 
Biotin is produced in minute quantities by micro-organisms and plants via a similar 
biosynthetic route that has few parallels in mammalian biochemistry, making it an 
attractive target for inhibition studies. 
This thesis describes the development of synthetic strategies for intermediates of the 
biotin biosynthetic pathway, and some structurally related compounds. 
An early step in biotin biogenesis is the decarboxylative condensation of pimeloyl-
CoA and L-alanine to give 8-amino-7-oxononanoic acid (AON), catalysed by the b/oF 
gene product, 8 -amino-7-oxononano ate synthase (AONS). A novel preparation of 
(+)-AON is described here, along with a description of various alternative strategies 
which have been employed in the synthesis of this, and related compounds. 
Dethiobiotin synthetase (DTBS), the penultimate enzyme in the biotin biosynthetic 
pathway, catalyses the incorporation of a carbonyl moiety between the adjacent amino 
groups of 7,8-diaminononanoic acid (DAN), in a process utilising ATP and carbon 
dioxide. A phosphorus containing structural analogue of a postulated intermediate in 
this process has been synthesised. 
The study of the interactions between these compounds and the purified enzymes will 
facilitate the design and development of mechanism-based enzyme-inhibitors. 
Abbreviations 
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ADP Adenosine diphosphate 
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DMF N,N-Dimethyl formamide 
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J Spin-spin coupling constant (in Hertz) 
LDA Lithium diisopropylamide 
in Multiplet 
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NI'vlIR Nuclear magnetic resonance 
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PLP Pyridoxal-5 '-phosphate 
PMP Pyridoxamine-5 '-phosphate 
ppm Parts per million 
pro Prochiral 
PTC Phase transfer catalysis 
PTC/OH Hydroxide-ion initiated phase transfer catalysis 
q Quartet 
RT Room Temperature 
SAM 	 S-Adenosyl-L-methionine 
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1.1 Biotin: A General introduction 
At the turn of the century, nutritional science was beginning to focus on the idea of 
micronutrients in the diet. Particular attention was concentrated on the yeast growth 
factor termed "bios", coenzyme R, a bacterial growth and respiration factor, and 
vitamin H, a rat nutrition factor. It was only realised a number of years later that 
these three lines of research were dealing with the same substance, biotin (1) which 
was subsequently shown to be a carboxylation cofactor. 
Figure 1: D-(+)-Biotin (1) 
Biotin was first isolated by Kogl and Tonnis in 1935, who obtained it as its crystalline 
methyl ester from 200 kg of dried egg yolk.1 Its structure was elucidated through 
degradative studies by Du Vigneaud and coworkers2 seven years later, with additional 
confirmation of its identity coming from the first total synthesis of (racemic) biotin by 
Harris et al. in 1944. 	X-ray crystallographic studies4' 5 revealed biotin to have a 
bicyclic structure consisting of a imidazolidone ring cis-fused to a tetrahydrothiophene 
ring. The valeric acid side chain, attached to the C-2 of the tetrahydrothiophene ring, 
is cis with respect to the ureido ring. (It may be noted that the separation between the 
C-6 and 3'-N atoms is 28.6 pm, significantly less than the combined van der Waal's 
radii of 35 pm, resulting in a considerable steric interaction). 
1.2 The Biological Role of Biotin 
It was with the discovery by Wakil et al.6 that biotin was an essential component in 
the acetyl-CoA carboxylase enzyme, that the central role of biotin in carboxylation 
1 
reactions was established. The isolation of biocytin (2) from yeast7 (see figure 2), by 
Wright and Skeggs led to the proposition that functionally active biotin was 
covalently fused, via an amide linkage to the c—amino group of a lysyl residue on the 
enzyme. Verification of this postulate came from the work of Kosow and Lane8 who 
demonstrated that biotin was indeed linked in this manner to the biotin-carrier protein 
(BCCP) of the propionyl-CoA carboxylase enzyme (see figure 2). 
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Figure 2: Biocytin (2) and biotin attached to the BCCIP 
The long flexible carbon-chain linking biotin and the carrier protein-subunit enables 
the prosthetic group to swing between the two catalytic domains of the carboxylase 
enzyme, allowing the transfer of the carboxyl group from the donor to the acceptor 
molecules. 
The carboxylases for which biotin has shown to have a definite cofactorial role, can be 
subdivided into three functional categories 
1) In the class 1 (carboxylation) enzymes biotin mediates the transfer of a carboxylate 
group from bicarbonate to acceptor molecules such as pyruvate, propionyl-CoA, 
acetyl-CoA, 13—methylcrotonyl-CoA, geranyl-CoA and urea. The ATP-dependent 
2 
carboxylation of biotin and subsequent transfer are summarised in the two partial 





enz-biotin + ATP + HCO3 	.-. 	enz-biotin-0O2 + ADP + P1 + H 
enz-biotin-0O2 + R-H 	 enz-biotin + R-0O2 
The class 2 (decarboxylation) enzymes mediate the transport of sodium ions in 
anaerobes and are linked to the decarboxylation of ft-ketoacids and their CoA 
thioesters, such as oxalacetate, (S)-rnethylmalonyl-CoA and glutaconyl-CoA. The 
processes involved can be summarised thus: 
enz-biotin + R-0O2 	 enz-biotin-0O2 + R-H 
enz-biotin-0O2 + 2 (Na) 11 	 enz-biotin + HCO3 + 2 (Na)01  
The only class 3 (transcarboxylation) enzyme is methylmalonyl-CoA : pyruvate 
carboxytransferase (EC 2.1.3.1), found in Propionibacterium shermanii, which 
couples the two following reactions: 
enz-biotin + oxaloacetate 	 - 	enz-biotin-0O2 + pyruvate 
enz-biotin-0O2 + propionyl-CoA . 	enz-biotin + methylmalonyl-CoA 
There are four biotin-dependent carboxylases important in human (vertebrate) 
biochemistry9  : J3-methylcrotonyl-CoA carboxylase (MCC) and propionyl-CoA 
carboxylase (PCC) are involved in amino acid metabolism, acetyl-CoA carboxylase 
(ACC) is a key enzyme in fatty acid biosynthesis (lipogenesis) and pyruvate 
carboxylase (PC) is the primary enzyme in gluconeogenisis (see figure 3). 
Due to the endogenous production of biotin by intestinal flora, 10 deficiency does not 
normally occur in man or higher vertebrates, even when a biotin-free diet is 
administered. The dietary requirement for man is not known with certainty, due to 
the poor understanding of the uptake mechanisms of biotin from the intestine, and of 
3 
the magnitude of biotin production in the gut. In humans, a deficiency in biotin may 
be induced by the consumption of a large amount of raw eggs, or egg white and by 
prolonged antibiotic treatment. Symptoms include alopecia, dermatitis, various 
metabolic disorders, nausea and behavioural abnormalities. However, remedial 
treatment with biotin supplements (dietary or intravenously) usually results in a full 
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Figure 3: Scheme showing the role of the four biotin-dependent 















1.3 Biotin-Avidin Technology 
The glycoprotein avidin, found in egg whites, has an extremely high binding affinity 
for biotin (KD = 10-l' M), that is unaffected by extremes of pH, salt concentrations or 
chaotropic reagents such as guanidine. 12  Avidin, and the analogous bacterial proteins 
streptavidin and streptavin (produced by Streplomyces microorganisms) specifically 
bind molecules containing a cis-imidazolidin-2-one moiety. Biotin may be coupled in 
a facile manner to a wide range of antigens, antibodies, enzymes and fluorescent 
markers without adversely affecting its strong affinity to avidin. This has provided 
researchers with a valuable tool for the study of biochemical and immunochernical 
processes in vitro. 13 
1.4 The Mechanism of Biotin Carboxylation 
The severe steric crowding between the 3'-N and C-6 of biotin 14  would suggest that 
the likely structure of carboxylated biotin would involve the reversible formation of a 
carbamate at the 1'-N position. This was shown to be the case by the isolation of the 
dirnethyl ester of 1'-N-carboxybiotin (4) by Lynen el al., ' 5 from the diazomethane 
trapping of the enzymatic intermediate in a model system where free (+)-biotin was 
carboxylated by 3-methylcrotonyI-CoA carboxylase in the presence of ATP and Mg2 . 
The x-ray analysis of the bis-p-bromoanilide derivative of carboxybiotin16 confirmed 
the position of the carboxy group on the 1'-N position (see figure 4). 
1 -N-carboxybiotin (3) 
	
(4) 
Figure 4 : 1'-N-Carboxybiotin (3) and its dimethyl ester (4) 
5 
The apparent chemical inertness of the N'-carboxy species led Bruice el al. 17 to 
suggest that the active enzymatic species was in fact 0-carboxybiotin, which 
rearranged to the more stable N-acyl compound during methylation and isolation. 
However, this initially attractive proposal was ruled out by the demonstration that 
synthetically prepared 1 '-N-carboxybiotinol was a chemically and kinetically 
competent substrate for the acetyl-CoA carboxylase enzyme. 18 
The question of whether CO2 or bicarbonate was the substrate in the carboxylation of 
biotin was addressed by Kaziro ci al. 19 in 1962, by tracer experiments using [18O3] 
bicarbonate as a substrate for propionyl-CoA carboxylase. Their finding that two 180 
atoms ended up in the carboxyl group of methylmalonyl-CoA, and the third resided in 
P, strongly suggested that HCO3 was the true substrate (but this did not rule out a 
subsequent dehydration in the active site to generate CO2). These experiments also 
showed that the bicarbonate ion is directly involved in the cleavage in the cleavage of 
the 13,y-bond of Mg-ATP. 
Of the large number of pathways proposed for the mechanism of carboxylation of 
biotin, three of the more 'mechanistically plausible' routes are summarised in figure 5. 
Pathway (A) (suggested by Kaziro' 9)  involves the preactivation of bicarbonate by 
ATP forming carboxyphosphate (5), which then directly, or after decomposition to 
enzyme-bound CO2 20  carboxylates the N'-1 of biotin. 
Pathway (B) (put forward by Lynen21) involves the activation of biotin by 
phosphorylation of the urea oxygen. The resultant phosphobiotin then reacts with 
bicarbonate possibly in a concerted six-electron pericyclic process, to generate N-i'-
carboxybiotin (3). 
Pathway (C)22 also involves the formation of 0-phosphobiotin as an intermediate, but 
this is then attacked by bicarbonate to generate carboxyphosphate (5) and the ureido 
anion of biotin, which in turn react (possibly with the pre-formation of CO2) to yield 
carboxybiotin. 
In an attempt to clarify the issue, Hansen and Knowles23 synthesised [7-170, 7-1801-
-y—phosphorothioate of ATP, a chiral analogue of ATP, and used this as a substrate 
for the pyruvate carboxylase enzyme. The rationale behind this experiment being that 
enzymatic displacements at phosphorus have been universally demonstrated to 
proceed with an 'in-line' geometry and invert the configuraton.24 Consequently 
pathways (A) and (B) are expected to proceed with inversion of configuration, with 
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Figure 5 : Three proposed mechanisms for the carboxylation of biotin 
7 
Determination of the chirality of the [160, 170, '80]-thiophosphate product revealed 
that the carboxylation process had proceeded with overall inversion of 
stereochemistry at the phosphorus centre, effectively ruling out pathway (C). Based 
on the complete lack of enzymatic precedent, the authors argued that postulated 
pseudorotatory effects (upon the formation of the 0-phosphobiotin) were unlikely to 
occur. 
Incubation studies by Lane and co-workers25 showed the ability of biotin carboxylase 
to produce ATP from Mg-ADP and carbamoyl-phosphate (an more stable, isosteric 
analogue of carboxyphosphate), thus supporting the intermediacy of 
carboxyphosphate (5) and hence pathway (A). This route implies that a ureido 
nitrogen of biotin functions as a nucleophile, a proposition that did not initially appear 
mechanistically attractive, but now appears to be the most likely path.26  
Despite intense research, none of the suggested mechanisms above have been fully 
verified experimentally, principally due to the problems associated with performing 
reliable isotopic exchange experiments on reversible processes, and the failure to trap 
any of the proposed intermediate species. 
1.4 The Mechanism of Carboxyl Transfer 
Through experiments on propionyl-CoA carboxylase , Retey and Lynen27 were able 
to demonstrate that carboxylation proceeds with retention of configuration at the 
carbon that accepts the carboxyl moiety. They also established that proton exchange 
between the solvent and substrate only occurred with enzymatic turnover. These 
observations led them to propose a concerted, pericyclic mechanism for the carboxyl 
transfer (reaction 1 in figure 6). 
However, the chemically-unprecedented nature of pathway (1) prompted further 
investigation to determine whether or not the mechanism was concerted or stepwise. 
Abeles and Stubbe28 found that the propionyl-CoA carboxylase enzyme catalysed the 












substrate carbanion, and hence a stepwise mechanism (2) was proposed. Knowles,26  
prompted by the results of kinetic experiments performed by Sauers and co- 
workers,20 has suggested a similar process where decarboxylation preceds the attack 
of the substrate carbanion (pathway 3). 
Further evidence supporting the operation of a stepwise mechanism was supplied by 
Knowles and O'Keefe29 and Cleland et al.30 who employed double isotope 
fractionation experiments to identify the rate determining steps in transcarboxylase 
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Figure 6 : Three proposed carboxyl-transfer mechanisms 
Knowles and O'Keefe correlated the kinetic isotope effects measured for the 
substrates [11-131- and [2H3]-pyruvate with the natural variation in '3C abundance of 
malonyl-CoA. Detailed kinetic analysis revealed that the rate of the carboxylation 
reaction was dependent upon a carbon-hydrogen and a carbon-carbon bond cleavage, 
with both processes displaying primary isotope effects. The authors demonstrated 
that the kinetic measurements were consistent with a 'balanced stepwise', and not a 
concerted mechanism. Cleland and coworkers30 drew parallel conclusions from the 
kinetic analysis of similar experiments performed on the pyruvate carboxylase 
catalysed process. 
1.6 The Elucidation of the Microbial Biotin Biosynthetic Pathway 
The microbial biotin biosynthetic pathway has been the subject of intensive study since 
the discovery of the true role of biotin in cell biochemistry in the early 1950's.3' A 
vast array of genetic manipulations, radiolabel feeding studies and substrate analogue 
incubations have been used, on a variety of bacterial strains, to elucidate the sequence 
of enzymatic conversions required to biosynthesise this vitamin. 
Early studies by Mueller et al.32 demonstrated that pimelic acid (6) could substitute 
for biotin in supporting the growth of certain strains of Cornebacterium diphtheriae. 
In the same year, Eakin and Eakin33 were able to show that the addition of pimelic 
acid and cysteine (or cystine) to a growing culture of Aspergillus niger increased the 
excretion of biotin vitamers into the growth medium. Dethiobiotin (10) was found by 
Du Vigneaud et al.34 to be as effective as biotin in supporting the growth of the yeast 
Saccharomyces cerevisiae. Evidence for the incorporation of the intact pimelic acid 
moiety into both dethiobiotin and biotin, in both Phycomyces blakesleeanus and 
Aspergi 1/us niger, was presented simultaneously in 1962 by Elford and Wright35 and 
Eisenberg36 using [1,7-' 4C]-pimelic acid. However, it must be noted that studies 
with other organisms failed to support this finding.37 
10 
Later that same year Lezius, Ringelman and Lynen38 put forward a proposal for a 
biotin biosynthetic pathway, based on isotopic studies with a species of 
Achromobacter grown on isovaleric acid, in the presence of either [3-14C]-L-cysteine 
or 14CO2. (see figure 7). The route starts with the condensation of three malonyl-CoA 
molecules, with the sulfur atom being incorpoated at an early stage, via the 
decarboxylative condensation of pimeloyl-CoA (7) with cysteine to generate 9-
mercapto-8-amino-7-oxopelargonate (11). However in their experiment, 40% of the 
label incorporated could not be localised and consequently the data does not exclude 
other biosynthetic routes including C2 degradation of a higher homologue, or C2 
addition to a lower homologue. Their rationale for the formation of dethiobiotin 
(isolated by Dittmer39 and Tatum40) was that it arose from the abortive condensation 
of pimeloyl-CoA with alanine. 
Acetyl-CoA 	Malonyl-CoA x 3 
CO, 	 2CO2 
0 
















SH 	9-mercapto dethiobiotin (12) 
- 	Biotin 
Figure 7: Biosynthetic route to biotin proposed by Lezius et al. 
Independent work by Eisenberg4143 and Iwahara,44'45 showed that [1,7-14C]-
pimelic acid was incorporated into an avidin-uncombinable vitamer, which could be 
transformed into labelled dethiobiotin or biotin. Both groups tentatively identified this 
compound as 7-keto-8-aminopelargonic acid (KAPA, 8 modern name 8-amino-7- 
11 
oxononanoate, AON) and suggested an intermediary role for this vitamer in biotin 
biosynthesis. The observations of Dittmer and Du Vigneaud34 and Pontecorvo,46  
that the growth of various bacterial strains could be promoted by the addition of 
certain pelargonic acid derivatives, led Okumura et al.47'48 to perform experiments 
in order to increase the production of monosodium glutamate (MSG) by a 
Brevibacterium species auxotrophic for biotin. By ordering the pelargonic acid 
derivatives in terms of the concentrations required for maximal MSG formation, they 
proposed another pathway to biotin (see figure 8). These findings were in agreement 
with the earlier proposals of Tatum40 who had suggested that sulfur was incorporated 
at a later stage in biotin biogenesis. 
Pirnelic acid 	 Oleic acid 
7,8-Diketopelargonic acid 	7-Amino-8-hydroxy pelargonic acid 
7-Keto-8-aminooelargonic acid 	7-Annno-8-ketopelargomc acid 
7,8-Diarninopelargonic acid 
Dethiobiotin 
Biotin di amino -carboxylic acid 
Biotin 
Figure 8 : Biosynthetic route to biotin proposed by Okumura 
Finally Eisenberg and Rolfe49 in 1968 proposed a biosynthetic route to biotin in E. 
coil (see figure 9). This was based upon earlier evidence but also rationalised the 
biotin vitamer excretion patterns of a number of mutant biotin auxotrophs of E. coil, 
in which they had identified the intermediates through their chromatographic 
properties. The pathway, which is now known to be ubiquitous in nature, starts with 
the decarboxylative condensation of L-alanine and pimeloyl-CoA (7) yielding 8-
amino-7-oxononanoic acid (AON, 8). Transamination leads to the formation of 7,8-
diaminononanoic acid (DAN, 9), into which a carbonyl moiety from CO2 is 
12 
subsequently inserted to generate dethiobiotin (DTB, 10). Finally a sulfur atom is 
incorporated into the molecule to give biotin (1). 
bioF 












































Figure 9: The biotin biosynthetic pathway (proposed by Eisenberg) 
1.7 Genetic Aspects of Biotm Biosynthesis in Escherichia coil 
1.7.1 The Biotin Operon 
Biotin biosynthesis in E. coil is controlled by the genes of the blo operon (biotin 
locus), which is located at 17 mm. on the genetic map, between the attachment site of 
the lambda prophage (attA.) and the uvrB gene of E. coil50 (see figure 10). 
Complementation analysis by Rolfe51 and Cleary and Campbell,52 indicated that the 
operon contained five complementation groups: bioA, bloB, bloC, bioD and bioF. 
13 
Cleary et a153 and Adhya et aL 54 established the order of the genes using deletion 
mapping. They concluded that the four genes bioB,F,C and D were transcribed as a 
unit from left to right, and bioA from right to left, from a promoter located between 
bioA and bloB (see figure 11). 
A further gene, b/oH55'56 has been found at a distant site on the map, but at this time 
little is known about its function except that it may encode for an enzyme necessary 
for the production of pimeloyl-CoA. Eisenberg56 also identified two other genes 
NO, a permeability gene, and b/oR a regulatory gene. Barker and Campbel157 later 
identified a gene known as birA, which was subsequently shown to be identical to the 





Figure 10 : The chromosomal locations of the E. coli bio genes (minutes) 
10 kb  I 	
6kb I 




Figure 11 : The bio operon 
14 
The genes of the bio operon 
bioA gene product - 7,8-Diaminononanoate synthase (430 a.a., 47 403 Da) 
bloB gene product - Biotin synthase (346 a.a., 38 665 Da) 
bioF gene product -: 8-Amino-7-oxononanoate synthase (384 a.a., 41 599 Da) 
bloC gene product - Unknown function, prior to pimeloyl-CoA (251 a.a., 28 322 Da) 
bioD gene product - Dethiobiotin synthetase (218 a.a., 23 917 Da) 
ORF-1 	- Open reading frame (158 a.a., 17 101 Da) 
bioR gene product - regulatory protein : B/rA (321 a.a., 35.3 kDa) 
h/oP gene product - permeability protein 
h/oH gene product - Unknown function, prior to pimeloyl-CoA (256 a.a., 28.5 kDa) 
1.7.2 Regulation of the Biotin Operon 
In 1965 Pai and Lichstein first showed that biotin biosynthesis in E. coil was 
controlled by the concentration of biotin in the growth media.58 Eisenberg later 
demonstrated that this was controlled by repression rather than feedback inhibition. 5 9 
Regulation of gene expression is now known to involve BIrA, a bifunctional protein 
that serves as a biotin activating enzyme and as a transcriptional regulator.60 B1rA 
converts biotin to biotinyl-AMP (biotinyl-5'-adenylic acid) which is the activated form 
required for ligation of biotin to the biotin carboxyl-carrier protein (BCCP). The 
intermediate in this reaction, the birA-biotinyl-AMP complex functions as a 
corepressor, binding to the 40 base-pair bio operator, repressing transcription of the 
biotin biosynthetic genes. Thus the BIrA protein synthesises its own corepressor 
which is a unique property amongst DNA binding proteins. Recent studies have 
determined the structure of the biotin-holoenzyme synthetase6' and its mechanism of 
binding to DNA. 62 
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1.8 The enzymes of Biotin Biogenesis in F. colt 
1.8.1 The Synthesis of Pimeloyl-Coenzyme A 
Pimelic acid (6) has been shown to stimulate the production of biotin vitamers in 
several bacterial species,63 but opinion is divided upon whether it is directly or 
indirectly used in the microbial biosynthetic pathway. 
A gene (b/oW) has been identified in higher plants64 and in Bacillus65 which encodes 
for a specific pimeloyl-CoA synthetase. The Bacillus sphaericus protein has been 
overexpressed and shown to be a homodimer, with a subunit mass of 28 kDa. It 
catalyses the ATP linked condensation between HSCoA and pimelic acid, yielding 
pimeloyl-CoA and pyrophosphate. However, an analogous gene has not thus far been 
identified in E. coli. 
Ploux65 established that the uptake of free pirnelate into the cell, although shown to 
be far more rapid in Bacillus, does occur in E. coli. This permeability problem with 
pimelate was suggested as a reason for the discrepancy between the results of 
experiments performed with different bacterial species,66 to determine whether or not 
pimelic acid was the immediate precursor to pimeloyl-CoA. 
Recent reports by Flint et al.67 and Ifuku ci a168 have shed more light upon the 
origin of the carbon atoms of pimeloyl-CoA in E. coli, and have reinforced some of 
the original propositions of Lynen and coworkers.38 Ifuku performed a number of 
labelling studies on a biotin-overproducing strain of E. coli, using [3-13C]-alanine, D-
[1-13C]-glucose, [1-13C]-acetate and [2-13C]-acetate as the sole carbon sources. 
Labelling patterns in DTB and biotin isolated from the growth medium were 
consistent with acetyl-CoA acting as the precursor for pimeloyl-CoA synthesis. 
Experiments by Flint have mirrored these findings, with the C-3, C-6 and C-8 atoms 
of biotin shown to originate from the C-i of acetate, and the C-2, C-7 and C-9 
coming from the C-2 of acetate (see figure 12). 
These results are in agreement with the earlier findings of Lynen et al.38 who 











CoA molecules, resulting in the two carboxyls of pimelate being metabolically 
distinct. Ifuku found that label was incorporated into the C-10 of biotin when [1-'3C] 
as well as [2-'3C]-acetate was used as the sole carbon source. This indicates that this 
carboxyl group may originate from the '3CO2 produced by the tricarboxylic acid 
(TCA) cycle. 
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Figure 12 : Proposed mechanism of acetate incorporation into biotin 
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It has been proposed that the b/oH and bloC genes in E. coil encode for two proteins 
involved in the biosynthesis of pimeloyl-CoA. At this time neither of the gene 
products have been isolated, and their nature and exact function remains 
unknown.6069 Lemoine et a170 have recently published a speculative paper in which 
they have suggested that the bloC gene product may act as an acyl-carrier protein 
(ACP), catalysing the stepwise condensation of the malonyl-CoA starter group to 
form pimeloyl-ACP. They have postulated that the b/oH protein then transfers the 
pimeloyl moiety from the active cysteinyl residue of bloC directly to coenzyme A, 
preventing the accumulation of free pimelate inside the cells. 	However, no 
experimental evidence has been presented to support these proposals. 











0 Pimeloyi-CoA (7) L-alacune 	 8-aipij,o-7--oxonona,,ojc acid (8) 
Figure 13: The AONS catalysed process 
8-Amino-7-oxononanoic acid synthase (AONS), the b/oF gene product, catalyses the 
decarboxylative condensation between pimeloyl-CoenzymeA (7) and L-alanine in a 
stereospecific manner. AONS shares a common requirement for the cofactor 
pyridoxal-5'-phosphate (PLP, 15) with three other a-oxoamine synthases :71,72 
i) 5-Aminolaevulinic acid synthase (ALAS), which catalyses the condensation 
between glycine and succinyl-CoA, the first step in porphyrin biosynthesis,73 ii) 
Glycine-acetyl transferase, which mediates the formation of 2-amino-3-oxobutanoate 
from acetyl-CoA and glycine74 and ill) Serine-palmitoyl transferase, which catalyses 
the condensation between palmitoyl-CoA and serine.75 Mechanistic studies on these 





In the ALAS mechanism, the first enzymatic step is the basic abstraction of the pro-R 
a-proton from the external aldirnine formed between PLP and glycine. The carbanion 
generated then condenses with succinyl-CoA to give the Schiff-base of a-amino-J3-
oxoadipic acid. Subsequent decarboxylation and transimination with an active site 
lysine residue, yields 5-aminolaevulinate (see figure 14). 
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Figure 14: Mechanism of 5-aminolaevulinic acid formation in ALAS 
The bioF gene product has recently been cloned from B. sphaericus, and 
overexpressed in E. coil.76  The purified protein is a dimer of 82 kDa, showing an 
absorption band at 425 nm, characteristic of a PLP-containing enzyme. Preliminary x- 
ray co-ordinates for the crystallised enzyme77 have been published, but as yet no 
structure for the Bacillus enzyme has been reported. 
The structure of the AONS enzyme from E. coil has recently been determined in our 
laboratory.72  The protein is a homodimer with a tertiary structure similar to, but 
distinct, from the other PLP-dependent enzymes whose three-dimensional structures 
are known. The active site residues have been identified, and a putative diphosphate 
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binding site for CoA has been located. (This will be discussed in more detail in the 
next chapter). 
Ploux and co-workers78 observed that when L-alanine was incubated with B. 
sphaericus AONS and PLP in deuterated water buffered at pD 7.0, there was a 
stereospecific, time-dependent exchange of the a—proton with deuterium which 
followed first order kinetics. A kinetic isotope effect on the reaction velocity (V), 
when L-[2H]- alanine was the substrate, DV = 1.3, was taken as indicating a partially 
rate limiting proton abstraction at that position (combined with a postulated partially 
rate-limiting reprotonation step). 
The above results have led Ploux el al. to suggest that the condensation follows an 
analogous mechanism to ALAS, with proton abstraction, and not decarboxylation, 
being the first step, and to propose that all the PLP-dependent a-oxoamine synthases 
share a common mode of action (see figure 15). 
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Figure 15: Proposed mechanism shared by a-oxoamine synthases (Ploux et aL) 
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Figure 16 : The bioA catalysed transamination process 
The bioA gene product, S-adenosyl-L-methionine : 8-amino-7-oxononanoic acid 
amino-transferase, or 7,8-diaminononanoate synthase (DANS), catalyses the 
stereospecific transfer of an amino group from S-adenosyl-L-methionine (SAM or 
Ado-met, 13) to the re face of AON (8) forming 8(S),7(R)-diaminononanoate 
(DAN, 9). The E. coli protein was purified to 86% homogeneity by Eisenberg and 
Stoner,79 and found to be a dimer with an estimated weight of 47000 ± 3000 kDa per 
subunit and an isoelectric point of 4.7. Eisenberg and Stoner" demonstrated that the 
a—amino group of SAM, and not that of L-methionine as Pai81  had originally 
suggested, was transferred. Pai's findings can now be attributed to a residual amount 
of Ado-met synthetase enzyme being present in the purified DAN-aminotransferase 
solution. 
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Pyridoxal.5'-.phosphate (14) 	Pyridox=ine-5'.phosphate (PMP) (15) S-adenosyl-L-methionine (SAM) (13) 
Figure 17: The structure of SAM, PLP and PMP 
The cofactor, pyridoxal-5'-phosphate (PLP, 14) is vital for enzymatic activity, with 
the amino group being transferred via a ping-pong mechanism from SAM (13) to the 
PLP, forming pyridoxamine-5'-phosphate (PMP, 15), and then to AON to yield DAN 
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0 
dethiobiotin (DTB) (10) 
and regenerate PLP.82 The implied product of the reaction, S-adenosyl-2-oxo-4-
methylthiobutyric acid (16), has never been isolated in any enzymatic incubations, and 
it has been suggested79 that it readily decomposes under non-enzymatic conditions to 
5'-methylthioadenosine and 2-oxo-3-butenoic acid (although these compounds have 
never been detected). 
Eisenberg31  has suggested that the bioA and bioF gene products could be derived 
from a common ancestral gene, due to the high similarity in function, substrate 
specificity and cofactorial requirements of the two proteins. Subsequent work by 
Otsuka83 showed that there was only 20% amino-acid homology between the hioA 
and b/oF products, although the PLP and SAM binding site homologies were found in 
similar positions on the proteins. It is noteworthy that there is a higher sequence 
homology, (27%) between DAN-arninotransferase from E. co/i and human ornithine 
arninotransferase (EC 2.6.1.13). Analogously there is a 41% sequence homology 
between 8-AON synthase from E. co/i and 5-aminolaevulinic acid synthase from 
Bradyrhyzobium/aponicurn (EC 2.3.1.37). This suggests that even though they may 
share a common ancestry, the hioA and h/oF genes probably diverged before the 
creation of vertebrates, as they now belong to two separate enzymatic families. 




Mg-ATP 	Mg-ADP + Pi 
DTBS 
7,8-diaminononanojc acid (DAN) (9) 
Figure 18: The DTBS-catalysed formation of dethiobiotin 
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Dethiobiotin synthetase (DTBS) catalyses the penultimate step in biotin biosynthesis 
(see figure 18), the formation of the ureido ring of biotin; converting DAN (9) to 
dethiobiotin (DTB, 10). It is one of the few CO2-utilising enzymes in nature that does 
not involve biotin as a prosthetic group, and the only one known to catalyse an N- 
carboxylation.84  
Studies with resting cells of a mutant strain of E. co/i85 unable to grow on 
dethiobiotin, provided the first direct evidence of a precursor-product relationship 
between DAN and DTB. Using cell free extracts, Eisenberg and KreIl86 were able to 
demonstrate the requirement for CO2, ATP and Mg2 , and the direct incorporation of 
a 14C0 moiety from 14CO2 into the ureido ring of dethiobiotin. After purification of 
the enzyme to near-homogeneity, Eisenberg and Kre1187 were able to show that the 
active form was a homodimer with a molecular weight of Ca. 42 kDa. Enzyme-
incubations with added avidin, and with carbonic anhydrase proved that CO2 and not 
HCO3 was the true substrate, and that biotin was not involved as a prosthetic group. 
These observations, combined with the identification of ADP as a product, led to the 
proposition of a three-step mechanism (see figure 19). 
	
H3N+ 	NH3 
















DTB (10) 	 2 
Figure 19 : Proposed mechanism of ureido-ring formation 
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The first step involves the reversible formation of a monocarbamate 17 from DAN 
and CO2. The next stage is the activation of the carbamate with ATP, forming a 
substituted carbamyl-phosphate 19. 	Subsequent nucleophilic attack from the 
(deprotonated) vicinal amino group at the reactive carbonyl centre generates the 
ureido ring of DTB, with phosphate being displaced. 
The cloning of the bioD gene from both Xb1o256 and from E. coil genomic DNA into 
a modified pBR322 derived plasmid, has allowed the DTBS enzyme to be 
overexpressed and purified to homogeneity.88 This has allowed a more detailed 
investigation into the intimate mechanism of the ureido ring-forming process to be 
undertaken. 
The stoichiometry of the overall process was confirmed by Baxter et al.,89 who 
through a linked assay system, proved that one mole of ATP was required to produce 
one mole of DTB, indicating that a single activation step is involved in the formation 
of two amide bonds. Baxter and co-workers also performed a number of radiolabel 
pulse-chase experiments to indicate the order in which the three substrates: DAN, 
CO2 and ATP were utilised by DTBS. These involved the pre-incubation of DTBS 
with i) H'4CO3 alone, ii) H'4CO3 and DAN or iii) H14CO3 and ATP, and after a five 
minute period, the addition of a 'chase' solution containing an excess of unlabelled 
bicarbonate and the other substrates. The finding that the largest degree of 
radioincorporation of 14C into DTB arose from the pre-incubation of DAN with 
H'4CO3 , indicated that the initial step was the formation of the carbamate. 
Whilst initial methylation trapping experiments suggested that the 8-amino-carbamate 
17 was the active enzyme-bound species,89 subsequent crystallographic information 
obtained via analysis of the enzyme-DAN-carbamate complex indicated that the 7- 
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Figure 20 : Mechanism of DAN-carbamate formation 
Evidence submitted by Gibson et al.92 stated that the diazomethane trapping of 
mixtures containing DAN, [14CO2], and a molar excess of DTBS, led to the isolation 
of four times as much labelled N-7-amino carbamate, as N-8-carbamate, suggesting 
that the enzyme preferentially formed the N-7-regioisomer. By analogy to the earlier 
experiments by Baxter et al.,89 pulse-chase experiments showed that the binary 
complex of DTBS and N-7-DAN-carbamate became kinetically committed upon the 
addition of MgATP. These authors also demonstrated the preference of DTBS to 
cyclise the DAN-N-7-carbamate mimic 20 to the corresponding lactam 21, compared 
to the weakly inhibitory properties of the N-8-DAN-carbamate mimic 22 (see figure 
21). It was conjectured that this showed the enzyme's specificity for carbamate 
formation and activation at the N-7 position. 
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Figure 21 : DTBS-Catalysed lactam formation (Gibson et al.) 
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Trapping experiments and stopped-flow, UV spectrophotometric measurements by 
Baxter et al.90 have suggested that the first reaction catalysed by DTBS proceeds in 
two stages. The initial step involves the binding of DAN to DTBS to form a 
substrate-enzyme complex 23. This is followed by the reaction of this complex with 
CO2  affording a DTBS-DAN-carbamate complex 24 (shown in figure 22). 
k1 	 k2 
DAN + DTBS 	- 	 DAN- DTBS + CO2 - 	 DAN- DTBS-0O2 
k1 	 (23) 	 k 2 	 (24) 
Figure 22: Kinetic model for the enzym e-s u bstrate-carbam ate complex 
formation 
Kinetic experiments conducted with and without Mg 21 ions indicated that neither the 
binding of CO2 to the enzyme, nor N-carboxylation, occur to any significant extent in 
the absence of Mg2 F• 
Through the incubation of the labelled substrate [1804]-'y,j3-['80]-ATP, plus DAN, 
bicarbonate and Mg2 ions, with DTBS, Baxter and Baxter93 were able to identify the 
reactive intermediate involved in the ring-closure process. Through the analysis of 
180 distribution in the products by 31P NAM, a principal ion peak corresponding to 
['803,160]-phosphate was detected, which implied the operation of pathway (B), and 
the intermediacy of the carboxy-phosphate mixed anhydride species 25 (see figure 
23). 
Subsequently Gibson94  through 	product analysis by 	high 	resolution 	mass 
spectrometry, was able to demonstrate that 180  was incorporated into both the 
inorganic phosphate and DTB formed in the DTBS catalysed reaction between DAN, 
ATP and C'802, in an 180-enriched aqueous buffer. She also identified a product 
(detectable by tic), capable of incorporating radiolabel from either 14CO2, [9-3H]- and 
[1,7- 14C]-DAN or [7-33P]-ATP, as the carbamyl-phosphate mixed anhydride 25. A 
solution containing 25 was separated from a DTBS incubation mixture quenched with 
ammonium acetate (pH 4), at low temperature. Subsequent kinetic experiments 
showed that the intermediate had a lifetime at 0 °C of ca. 25 minutes at pH 7.5. 
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Figure 23 : Two possible ring-closure mechanisms 
Gibson has also shown that the ratio of radiolabel incorporated into DAN and DTB, 
obtained after either acidic or basic treatment of pre-incubated mixtures of DTBS, 
DAN ATP and 14CO2, is consistent with the intermediacy of a mixed anhydride 
species. The rationale here relies on the likelihood of the mixed anhydride being 
hydrolysed under acidic conditions, and ring-closing under basic conditions (as shown 
in scheme 24). 
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Figure 24 : Decomposition of the reactive intermediate 
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The availability of highly purified dethiobiotin synthetase has allowed its crystallisation 
and subsequent x-ray structural refinement to atomic resolution. Two groups 84, 95 
have independently determined the structure of DTBS from E. coil, and these studies 
agree on the majority of issues. The DTBS monomer has been shown to consist of 
one subunit, belonging to the class of a/13 domains. This is folded into a compact 
structure, with a central twisted 13-sheet forming a core surrounded by cc-helices 
(shown in figure 25). 
Figure 25: General view of the DTBS dimer 
The dimer is saucer-shaped, with the concave surface between the monomer units 
housing the putative active site. The two monomers have an extensive contact area, 
with many of the interactions mediated by water molecules. This may facilitate the 
relative movement of the monomers which is thought to occur during enzyme 
turnover. 
Alexeev et ai. 84  found that two sulfate ions were located at the base of the concave 
surface of the dimer, consistent with the positions of the phosphates in the ATP-
binding site. One of the sulfates (Si in figure 26) was positioned exactly in the loop 
formed by residues 8-16, indicative of a mononucleotide binding motif known as the 
P-loop 96 
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Subsequently, x-ray analysis ofDTBS which had been soaked with a solution of DAN 
and Mg2 90,  revealed that the substrate binding site was located between the 
interface of the two subunits (see figure 26). One of the carboxylate oxygens was 
shown to bind to the main-chain nitrogen of Asn-153, with the other held between the 
positively polarised peptide nitrogens of Gly-1 50-Cysi 5 1-Ile-1 52 (at the start of helix 
a6), and the hydroxyl of Tyr187, which had moved to optimise substrate binding. In 
solution, this rotation was accompanied by a significant change in the absorption 
spectrum at 290-300 nm (in the absence of ATP). The hydrophobic alkyl chain of the 
bound DAN was positioned in a groove defined by the Ca of Glyl 88, Cy of Thr122, 
Ca of Ser8l and Co of Pro82 on the other subunit of the native structure. 
X-ray structures of the DTBS-DAN-Mg2 complex in the presence of CO2 90, 
revealed the formation of a mono-carbamate at the N-7 position of the substrate. The 
(S2) sulfate ion (in figure 26), which was present before DAN carboxylation, is 
replaced by the carboxylate group of the DAN-carbamate and a water molecule (see 
figure 27). Thri 1 becomes coordinated to water molecule WI rather than to the N-8 
amino group of the substrate, and WI in turn forms hydrogen bonds with the oxygen 
of the DAN-carbamate and the c-amino group of Lys 15. 
P-loop 
Na 
Figure 26 : The binding of DAN to DTBS under an atmosphere of N2 
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Figure 27: The binding of DAN to DTBS under an atmosphere of CO2 
The essential roles of Lys 15 and Lys37 were demonstrated by Yang et al. 97  through 
mutational studies, which showed that replacement of either one of these residues led 
to almost complete loss of enzymatic activity. The replacement of Thrl 1 with valine 
resulted in a 24 000-fold increase in the observed KM(ATP), which led the authors to 
conjecture that this residue was essential for the steady-state affinity for ATP. 
In DTBS the topology of the P-loop is identical to the classical mononucleotide-
binding fold, but the sequence contains an extra residue. This forms a small bulge in 
the middle of the loop, occupied by Thril, which is hydrogen-bonded to the N-8 
amino group of the substrate. This interaction is essential for the correct orientation 
of the N-7 amine to allow carboxylation. Hence the extended P-loop simultaneously 
binds both the ATP and the substrate, bringing them together in order to facilitate the 
carbamate phosphorylation 90• 
Lindqvist et al 98  have obtained electron density images by x-ray kinetic 
crystallography, showing the enzyme-MgADP-carbamic-phosphoric acid anhydride 
binding to the putative active-site residues. The relative position of the N-7 nitrogen 
atom of DAN, and the y-phosphate of ATP, have led the authors to conjecture that 
the nucleophilic attack of the N-7 carbamate oxygen, on the the y-phosphorus atom 
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occurs with an in-line geometry. The transferred phosphoryl group was found to have 
moved Ca. 1.4 A from its position in the ATP complex, to the one observed in the 
intermediate complex. This suggests that the reaction may proceed with inversion of 
configuration at the phosphorus atom. 
The primary sequence of DTBS shows little homology with other proteins, except the 
analogous enzymes from B. sphaericus99 Serralia marcesens,100 Brevibacteriurn 
flavum 10l and Mycobacterium leprae. 102 However, the 3-D structure reveals 
similarities with three proteins of unrelated sequence and function; nitrogenase iron 
protein (NIP) from Azotobacter vinelandli, adenylosuccinate synthetase (purA) from 
E. coil and the Ha-ras oncogene product p21 84  All four enzymes are homodimers, 
but there is no similarity in the dimer organisation. There is however a shared P-loop 
motif, which suggests that nucleotide binding may be the major common feature 
between this diverse group of enzymes.90  
1. 8.5 The bloB Gene Product Biotin Synthase 
Biotin synthase catalyses the final step in biotin biosynthesis, the incorporation of a 









Figure 28 : The biotin synthase catalysed process 
1.8.5.1 The Sulfur Donor 
Lezius et al.38 in their original proposal for the biotin biosynthetic pathway used 
tracer studies with Achromobacter as a basis for their suggestion of a precusorial role 
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for L-cysteine. However reinvestigation by Marquet et al. 103  using incorporation 
experiments with [3-14C,35S]-cysteine, failed to yield radioactive biotin and 
demonstrated that this pathway was non-operational in Achromobacter. Niimura ci 
al., 104 using sulfur-starved cells of S. cerevisiae, found that methionine, methionine 
sulfoxide and Na2S were the most effective sulfur donors, and that cysteine and 
cystine were inactive. 	Labelling experiments105 with [35S]-methionine gave 
radioactive biotin, a result later corroborated by Shimada106 with tracer studies in A. 
Niger. These apparently anomalous results may be due the cells being unable to 
incorporate exogenously supplied cysteine, as it has been demonstrated in E. coil that 
only cystine can be transported and metabolised by the cell. 107 
Although lipoic acid was shown to have a stimulatory effect upon biotin production in 
A. niger, only low levels of [35S] incorporation were observed when [35S]-lipoic acid 
was administered, suggesting that lipoate was not the sulfur donor. 108 
NH, 	 NH2 
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Figure 29 : Thiocystine (26) 
Thiocystine (26), a source of both organic reduced sulfur (i.e. as cysteine), and 
inorganic sulfane, has been used by a number of researchers to probe the mechanism 
of sulfur uptake into biotin. Radiolabelling feeding experiments with thiocysteine, 
carried out by White 109 found that both forms of sulfur were incorporated into biotin 
in approximately equal amounts. However, DeMoll and Shive''011' using 
competitive feeding experiments, demonstrated that cysteine was a more effective 
sulfur donor than thiocystine in E. coil, and that radiolabel from [35S]-methionine was 
not incorporated into biotin. 
Recent studies on cell-free systems' 12  suggest that cysteine is the source of sulfur in 
biotin biosynthesis, but this remains to be proven in purified systems. 
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1.8.5.2 The Mechanism of Biotin Synthase 
On the basis of radiolabel feeding studies with A. niger, Li et a!1 13  conjectured that 
the conversion of DTB to biotin involved two desaturation steps in the overall 
mechanism. However, uncertainties arising from the use of randomly tritiated DTB in 
these double label experiments prompted Parry to reinvestigate these findings through 
the administration of specifically tritiated forms of dethiobiotin. These studies' 14,115 
revealed that the introduction of sulfur at the C-6 and C-9 positions took place 
without loss of hydrogen from C-7, C-8 or C-5. This suggests that a mechanism 
which involves desaturation at these positions is unlikely, although it does not exclude 
the possibility of specific enzymatic proton removal and replacement at these sites. 
Parry showed that the incorporation of [9-3H]-(±)-DTB into biotin proceeded with ca. 
30 % tritium loss, and that 6(RS)[6-3H]-(±)-DTB was incorporated with 47 % tritium 
loss. Both of these results are consistent with the removal of one hydrogen from the 
C-9, and one hydrogen from the C-6 positions in the enzymatic transformation. 
Parry's work with the eukaryotic A. niger was complemented by research from 
Marquet's group with the prokaryotic E. coli organism,' 16,117  who found that the 
administration of [7,8)H]-(±)-, [7,8-2H2]-(±)- and [5-2H2]-(±)-DTB resulted in the 
formation of biotin with no loss of label. 
The synthesis of chirally tritiated dethiobiotin by Parry 118  has allowed the precise 
nature of the stereochemical events occurring at the C-6 position, during the sulfur 
insertion process to be elucidated. [6-(R)-3H]-dethiobiotin (27) yielded biotin with 91 
% retention of label upon administration with 10-'4C dethiobiotin to A. niger, whereas 
[6-(S)-3H]-dethiobiotin (28) yielded biotin with 93 % loss of label. Thus the 6-pro-S-
hydrogen is lost at the C-6 position with retention of configuration. 
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Figure 30 : Chirally tritiated DTB molecules (Parry et aL) 
Arigoni1 19 attempted to investigate the stereochemistry at the C-9 position, through 
feeding studies using DTB containing a chirally labelled methyl group ([9-3H, 2H]-
dethiobiotin, 29). The isolation of biotin configurationally scrambled at the C-5 
position (i.e. the tetrahydrothiophene ring methylene), led to the proposition that 
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Figure 31: Proposed mechanism of scrambling (Arigoni etal.) 
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Whilst the retention of stereochemistry at the C-6 observed in the bioconversion of 
DTB to biotin suggests that the functionalisation mechanism may be a single step 
process, both hydroxyls120121  and thiols122123 have been proposed as 
intermediates. 
Marquet120 has provided evidence against the intermediacy of hydroxylated forms of 
dethiobiotin by showing that neither 9-hydroxydethiobiotin nor 6(R)- and 6(S)-
hydroxydethiobiotin could support the growth of the E. coil C124 mutant auxotroph. 
This was supported by the findings of Emoto et al.  121 through analogous studies 
with 6,9-dihydroxydethiobiotin. 	However, these results do not rule out the 
involvement of transient enzyme-bound hydroxylated intermediates. 
The thiol containing compounds 6- and 9-mercaptodethiobiotin, have been proposed 
as intermediates in the tetrahydrothiophene ring-forming process (see figure 










Figure 31: Proposed thiol intermediates 
Baxter123 has shown that synthesised (+)-9-mercaptodethiobiotin (30) can support 
normal growth of an E. coil bioA mutant (strain 6435) which requires DAN, DTB or 
biotin for growth. Marquet et al. 122  demonstrated that the secondary thiol 31 and to 
a lesser extent 30 could replace DTB or biotin in a biotin-auxotrophic strain of B. 
sphaericus. However, labelling studies using [35S]-(31) produced biotin devoid of 
radioactivity. Biological evaluation of the thiols 30 and 31 in resting cells of B. 
sphaericus revealed that only the primary thiol 30 was transformed into biotin with 
only 10 % observed conversion yield compared with dethiobiotin. However, 
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subsequent incubation of [35S1-(12) with the resting cells in the presence of DTT 
indicated clearly that the thiol was converted into biotin without degradation. 
A recent investigation by Baldet124 has identified 12 as an intermediate in the biotin 
biosynthetic pathway in cells of Lavandula vera. The isolated thiol was subsequently 
shown to be as effective as biotin in supporting the growth of the bloB 105 strain of E. 
co/i. Shawl 12  has recently reported the isolation of 12 from a cell free extract 
containing biotin synthase from E. co/i, providing additional evidence supporting the 
intermediacy of 9-mecaptodethiobiotin (12) in the biotin synthase process. 
The development of overexpression systems capable of producing relatively large 
amounts of protein in bloB transfromants has led to the purification of the protein 
encoded by the E. co/i bloB gene. 125  The active form of the bloB gene product 
appears to be a homodimer (82 kDa) which contains one [2Fe-2S] cluster per 
monomer. However, the bloB gene product alone is incapable of converting 
dethiobiotin to biotin, with an additional number of other proteins and low molecular 
weight compounds being essential for catalytic competence in cell-free extracts. The 
components which have thus far been suggested to be essential' 12  are; flavodoxin, 
flavodoxin NADPH-dependent oxidoreductase, a third protein fraction that requires 
thiamine pyrophosphate to maintain its activity during purification, cysteine, S-
adenosylmethionine, Fe2 , thiamine pyrophosphate, one of the amino acids asparagine, 
aspartate, glutamine or serine, and NADPH. 
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1.9 The Aims of Research 
Recent studies have suggested that the biosynthesis of biotin proceeds by an 
apparently identical pathway in higher plants, fungi and bacteria,124 via 
transformations that have few parallels in mammalian biochemistry. Higher organisms 
such as humans, do not need to synthesise their own biotin as a sufficient amount is 
produced by enteric flora. These facts, allied with the lack of an active transport 
system for biotin in plants and micoorganisms, makes the biosynthetic pathway an 
attractive target for inhibition studies. Consequently, the main corpus of this research 
was directed towards the identification of, and the development of synthetic 
approaches to, possible inhibitors of biotin biosynthesis. 
The first main objective was to synthesise the first two intermediates of the biotin 
biosynthetic pathway: namely pimeloyl-Coenzyme A and 8-amino-7-oxononanoic acid 
(AON), to be used in the study of the AONS and DANS enzymes from E. co/i. The 
second objective was to develop general methodology applicable to the synthesis of 
compounds structurally related to AON. 
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Chapter Two 
The Synthesis of Intermediates from the Biotm Biosynthetic Pathway 
2.1 The (Chemical) Synthesis of Pimeloyl-CoA 
Two methods for the synthesis of pimeloyl-CoA (7) have been reported in the 
literature: i) a pimeloyl-CoA synthetase (from B. phaericus) catalysed condensation 
of HSCoA and pimelic acid, 124 and ii) a trans-thioesterification reaction involving the 
displacement of an aromatic thiol from pimelic acid by coenzyme A, in a mildly basic 
solution.59'76 However, the reports on these procedures are extremely vague, and 
none of the authors give yields or proper analytical data on the product. Indeed, most 
have relied upon a hydroxamate,76,26 or Ellman's-type59"26 assay to estimate 
both purity and yield. 
The procedure we selected for the synthesis of pimeloyl-CoA (7), was that described 
by Ploux et al. 76 (see figure 32). 
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Figure 32: Synthesis of pimeloyl-CoA 
Treatment of the di-acid chloride of pimelic acid with thiophenol in DCM afforded the 
thiophenol mono-ester 32 in 32 % yield. The low yield is due to the formation of a 
significant amount of the dithioester. However, we elected not to optimise this step 
as 32 could easily be separated from the reaction mixture and only small amounts 
were required. The treatment of HSCoA with 32 in aq. NaHCO3 at pH 8 gave the 
desired product 7, contaminated with unreacted starting materials and hydrolysis by-
products. This was extracted with DCM to remove thiophenyl pimelate, thiophenol 
and pimelic acid, leaving an aqueous layer containing 7 and HSCoA. 
Two protocols were evaluated for the purification of the product. The first method 
used was anion-exchange chromatography (using a MONO-Q column on FPLC), 
eluting with a linear gradient of 0 to 1.5 M triethylammonium buffer. The eluant was 
monitored continuously at 260 nm. Unreacted HSCoA was the main contaminant, 
and eluted before the pimeloyl-CoA. Lyophilisation of the product containing 
fractions afforded 7 as a colourless solid which was characterised by mass 
spectrometry (MALDI-TOF, ff1 910.0) and by the comparison of its 
chromatographic properties on paper with those reported in the literature. 59 
The second protocol employed was preparative reverse-phase HPLC, which was 
found to a more efficient method of purification. A 5-50 % linear acetonitrile / water 
gradient over 30 minutes was found to be optimal. The eluant was continuously 
monitored at ? = 214 nm, so that non-aromatic impurities (i.e. compounds that did 
not contain an adenine, or a thiophenol moiety) and salts could also be detected, 
giving a better indication of the product purity. 
Initially the yields of pimeloyl-CoA obtained were less than 10%, although by 
modification of the reaction conditions and changing the method of purification, this 
was improved to Ca. 60%. It was observed that maintenance of the correct pH during 
the reaction course was of critical importance, and the use an inert atmosphere 
(preventing HSCoA oxidation) was also advantageous. 
2.2 The Synthesis of 8-amino-7-oxononanoic acid (AON) 
2.2.1 The First Synthetic Approach to AON 
Prior to this work the only reported synthesis of 8-amino-7-oxononanoate (AON) 
(trivial name 7-keto-8-aminopelargonic acid, KAPA) was in a Japanese patent. 127 
However, as other laboratories had encountered problems in repeating this procedure 
it was decided that a new synthetic route would be undertaken. 
Previous work in our laboratories towards the synthesis of AON-related compounds 
had centred on the use of cyclohexane derivatives such as 33 being key intermediates 
in the overall synthetic strategy (see figure 33). This type of methodology has been 
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used extensively in the literature in the preparation of various 1 ,6-difunctional 
compounds. 128  The Baeyer Villiger oxidaton129 of the cyclohexane ring to afford 
the corresponding lactone, and the functional group interconversion (FGI) of the 
alcohol to the amine (shown in figure 33) were completed successfully, by a previous 
lab worker, for R = Et and Me, to generate 6-aminooctanoic acid and 6- 
aminoheptanoic acid respectively. 130 
OH 	 NH, 
R.t7 '.c0R 	--- 
Figure 33 : The preparation of long-chain amino-acids 
In the first attempted synthesis of 8-(FS)-amino-7-oxononanoic acid (8), a strategy 
related to the one above was formulated (see figure 34). Enamine chemistry could be 
used to construct a substituted cyclic ketone 36, which could be oxidised under 
Baeyer-Villiger conditions to give the corresponding lactone 37. De-methylation of 
the ether moiety, possibly by iodotrimethylsilane,13 ' would give the hydroxyl 
compound 38, which could then be selectively converted to the amine 34, whilst the 
adjacent hydroxyl remained protected as a lactone (corresponding to the three dashed 
arrows). 	Subsequent methoxide-mediated lactone ring-opening, followed by 
oxidation and saponification would give the desired product, (±)-AON. 
Cycloheptanone was converted to its morpholine enamine 35 in moderate yield as 
described by Stork el al.. 132  Lewis-acid catalysed condensation of 35 with the 
dimethyl acetal of acetaldehyde133 proceeded in modest yield, with significant 
amounts of polymeric impurities being formed. The two expected diastereomers were 
formed in a 2 : I ratio, as estimated by the comparison of the integrals associated with 
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the methyl protons at the C-9 and C-10 positions. However it was not possible to 
assign specific resonances to either the threo or the erythro diastereomers due to the 
complicated, and broad nature of the NIMIR spectrum obtained (due to the various 
conformations that may be adopted by the cycloheptane ring). The multiplet at 3.59 
ppm (associated with the C-8 methine proton) is poorly defined, and the signal due to 
the C-7 methine proton is hidden under the complex broad multiplet corresponding to 







Figure 34: First attempted route to (±)-AON 
The Baeyer-Villiger lactonisation of the diastereomeric cyclic ketones 36 to afford the 
substituted lactones 37 proved extremely problematic, and could not be successfully 
performed under a variety of oxidative conditions. The reaction of 36 with m-
chloroperbenzoic acid, trifluoro-peracetic acid (generated in situ from trifluoroacetic 
anhydride and urea-hydrogen peroxide) and urea-hydrogen peroxideb34 under 
various conditions did not give any detectable amounts of the desired compounds. 
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A number of examples where alkyl-substituted cycloheptanones have been 
stereo specifically oxidised to the corresponding octolactones have been reported in 
the literature. 13 5,136 Analogously, investigations performed within our laboratories 
137 have shown that the Baeyer-Villiger oxidation of the a—methyl, and a-ethyl 
derivatives of cycloheptanone proceed cleanly and in high yield with various oxidants, 
to give the corresponding substituted cyclic lactones. This makes the failure of this 
particular Baeyer-Villiger oxidation appear quite unique. 
With the considerable problems associated with the oxidation of the ketone 
encountered at a fairly early stage in the reaction pathway, this approach was 
abandoned and an alternative strategy was developed. 
2.2.2 The Second Synthetic Approach to (±)-AON 
Dauben and Walker 138  relied on the alkylation of the anion of ketothioacetal 38 with 
ethyl 3-bromopropanoate, to generate a key intermediate 39 in their total synthesis of 
the sesquiterpene isocomene (see figure 35). 
0 	 0 
Br 	 )I Co2EI 
(38) 	 (39) 
Figure 35 : Synthesis of the a-oxodithiolane in Isocomene Synthesis 
If ethyl 6-bromohexanoate was used instead of ethyl 3-bromopropanoate, this would 
generate the desired nonanoic acid backbone with a mono-thioketal-protected a-
diketone moiety at the 7 and 8 positions. The reductive amination of the free ketonic-
carbonyl would yield a masked a-oxoarnine, which could be deprotected to give the 
desired product, (±)-AON (see scheme 36). 
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Figure 36 : Synthesis of (±)-8-amino-7-oxononanoic acid 
The synthesis of acetyl-dithiolane 38 was performed as described by Leir,'39 in a two 
step process with an overall yield of 55 % (see figure 37). The purification of the 
intermediate 42 proved non essential, and the desired product could be obtained as a 
(pungent smelling) golden oil by distillation of the final crude reaction mixture. 
CO2Et -2HCI 
HS 	SH 	 CIS 	SCI 	 OEt 
-EtOH 	\J 
(42) 	 (38) 
Figure 37 : Synthesis of 2-acetyl-1,3-dithioloane (38) 
However, the alkylation of the lithiate of 38, to generate the a-oxodithiolane 39 
proved more difficult. Reaction of dithiolane 38 with LDA in TI-IF at -78°C, gave a 
deep red-coloured anion that was unreactive towards ethyl 6-bromohexanoate, even 
in excess, for prolonged periods, and at elevated temperatures. This proved also to be 
the case when DMF, or HIVIPA were used as co-solvents. 
The bromo-ester was quantitatively converted to the more reactive iodo-compound 
43 via reaction with sodium iodide.'40 '41 When a solution containing a slight 
molar excess of 43 in 1-IMIPA, was added to the lithiate of 38 in TI-IF at -78°C and the 
reaction was allowed to proceed at RT for 24 hours, the desired product 39 was 
isolated in 96% yield. 
The reductive amination of the ketone 39 was initially performed using the conditions 
described by Borch and el at. 142 using ammonium acetate. The yields of amine 40 
obtained from the reaction were capricious and never above 50 %, even when the 
regents were scrupulously purified before use. Changing the dehydration agent from 
4A to 3A molecular sieves, or to CaC12, and altering the molar ratio of sodium 
cyanoborohydride present, had little effect upon the yield of 40 obtained. 
Another drawback from the use of this one-pot, imine formation and reduction 
process, was the significant level of alcohol 41 formed in a side reaction, from the 
cyanoborohydride reduction of the unreacted ketonic compound 39. 
An attempt to recycle the alcohol byproduct 41, via a Jones oxidation143 of the 
hydroxyl function, to give the starting ketone 39 was unsuccessful. The sole isolated 
products were tentatively assigned as an inseparable mixture of cis and trans ethyl 8-
oxo-7-(1,3-dithiolan-1,3-dioxide)-nonanoate (44) (see figure 38). 







(41) 	 (44) 
Figure 38: Oxidation of the alcohol 41 
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Because of the complications with the Borch reductive amination an alternative two- 
step procedure was evaluated. 144  Ketone 39 was reacted with hexamethyl disilazane, 
then reduced with a methanolic solution of NaCNBH3. Hydrolytic workup afforded 
the primary amine 40 (see figure 39). The use of this method eliminated the formation 
of the alcohol byproduct 41, but led only to a modest improvement in the amount of 
40 obtained (ca. 60%). 
o 	 Me3Si... 	 Me,Si.. 	 NH2 
N 	 NH 	 (40) 
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Figure 39: Reductive amination of 39 with hexamethyl-disilazane I NaCNBH3 
The removal of the thio-acetal protecting group of 40 was achieved rapidly (5 
minutes) and in high yield (>90 %) by the addition a solution of 40 in acetonitrile, to a 
stirred solution of N-bromosuccinimide in ice-cold 80 % aq. acetonitrile. 145  The 
crude product from this step was not purified, but was immediately added to a dilute 
aqueous solution of acetic acid and HCI to afford the N-protonated form. This 
reduced the potential for self condensation of the product. Previous work in our 
laboratories had demonstrated that a-oxoamines are prone to rapid pyrazine 
formation under neutral or basic conditions 146  (see figure 40). 





Figure 40 : Pyrazine formation via self-condensation 
The AON salt formed, was separated from succinimide, and other minor impurities, 
by ion exchange chromatography on Dowex-50X resin (H form) eluting with a linear 
0 to 1.5 M HC1 gradient. Lyophilisation afforded (±)-8-amino-7-oxononanoic acid as 
its hydrochloride salt. 	The colourless crystalline material is stable at room 
temperature, and is not extremely hydroscopic. 
2.3 The Synthesis of 8(S)-amino-7-oxononanoic acid 
With a satisfactory preparation of the racemic product developed, we began work on 
developing a stereospecific route to 8(S)-amino-7-oxononanoic acid, the biologically 
active isomer. 
A small number of methods for the synthesis of chiral a.-oxoamines exist in the 
literature. 147,148  Schollkopf et al. 147  have synthesised a selection of ct-oxo-a-
amino-acid esters by the reaction of lithiated bis-lactim ethers of 2,5-diketopiperazines 
with acid chlorides, followed by acidic hydrolysis. Holladay and Rich in their 
synthesis of a statine isostere,148 utilised a Grignard addition to Boc-protected 
leucinal, followed by an oxidation, to generate a chiral a-oxoamine. Analogously, N-
protected amino-acid aldehydes have been utilised extensively in the synthesis of 
chiral f3-amino alcohols.'49 '50 
Previous work in our laboratories146 has shown that N-Boc protected alaninal 45, 
was unreactive to long-chain Grignard reagents such as 50 (see figure 41). 
Consequently we decided to synthesise N,N-dibenzyl-alaninal 47, as it has been 
demonstrated that this is reactive to a wide range of nucleophilic reagents, 151,152 
including Grignard reagents, to afford a wide range of 13-amino alcohols in high yield, 
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Figure 41 : Previously-attempted Grignard addition (Wang Pu) 
The synthesis and subsequent reaction of N,N-dibenzyl-alaninal with long-chain 
carbon nucleophiles, should indicate whether the N-Boc-aldehyde is inherently less 
47 
reactive, or whether its chemical inertness is due to the nature of the nucleophile used, 
and the conditions employed. 
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Figure 42 : Proposed route to 8-(S)-AON (hydrochloride salt) 
The benzyl ester 48 was prepared in 76 % yield from L-alanine and benzyl bromide 
using a standard procedure.15' 	The ester was smoothly reduced to the 
corresponding alcohol 49, within 4 hours using a 3 molar equivalence of LiAIH4 
slurried in dry ether at OC,153 in 84 % isolated yield. Using methodology previously 
developed in our laboratories, 146 the bromo-ether 46 was prepared in 36% yield from 
1, 6-dibromohexane and sodium benzoxide. 
At this point in the synthesis of 8-(S)-amino-7-oxononanoic acid (HCl salt), 
Mioskowski et al. 154 published a stereospecific synthesis of both the (R) and (S) 
enantiomers of AON. This was accomplished by a similar route starting with N-Boc- 
alanine as shown in figure 43. For this reason it was decided not to pursue the 
synthesis further. 
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Figure 43: Synthesis of 8(S)-AON (Mioskowski et al.) 
2.4 The Biosynthesis of 8-amino-7-oxonoanoate in E. coli 
2.4.1 The Cofactor Pyridoxal-5'-Phosphate 
The first two enzymes of the known biotin biosynthetic pathway in E. coil are 
dependent upon the cofactor pyridoxal-5 '-phosphate 	56 




Deaminases and transaminases 
Decarboxylative synthases 
Enzymes which catalyse elimination / addition reactions 
The cofactorial role of PLP in these enzymes is to act as an electron sink, and stabilise 
carbanionic intermediates that develop during enzymatic catalysis. The conjugation 
between the imine and the hetero-aromatic pyridine ring results in an efficient 
delocalisation of negative charge. 
The PLP-dependent enzymes function via: 
initial imine formation, 
chemical transformations via carbanionic intermediates, and 
hydrolysis of the product imine 
Pyridoxal phosphate catalyses a wide variety of chemical reactions at the a—,J3—and '-
positions of the common amino-acids, and at the corresponding positions of other 
biologically important amino compounds. Both the bioF and bioA gene products 
utilise the chemistry of PLP to afford chemical transformations at the ct—carbon 
centre. 
Dunathan' 55 has postulated that the residues within the active site are positioned so 
as to orientate the PLP-external aldimine in a certain way, to place one of the Ca 
sustituents perpendicular to the plane of the aldimine ic-system. This 'freezing' of 
rotation around the Ca-N bond can be achieved through a combination of ionic and 
steric interactions between the substrate and the active site residues. This particular 
G-bond will then be cleaved in a facilitated manner due to the large overlap between 
its HOMO with the LUMO of the extended ic-system of the imine and the pyridinium 
ring (see figure 44). X-ray crystallographic studies have shown this relationship to 
hold true for all the systems studied. 156 
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Figure 44: Diagram showing the a-hydrogen bond orientated perpendicular to 
the plane of the conjugated it-system of the PLP-aldimine 
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Thus it is the nature of the enzyme that governs the reactivity of the substrate-PLP 
aldimine, leading to a specific pathway of catalysis being followed. This prevents the 
wide variety of reactions which PLP can catalyse from occurring simultaneously. 
Consequently the efficacy of the enzyme lies not only in the facilitation of certain 
chemical processes, but in the prevention of possible alternatives. 
2.4.2 The Structure and Proposed Mechanism of AONS from E. coli 
AONS, along with 5-aminolaevulinate synthase (ALAS), serine palmitoyl transferase 
and 2-amino-3-oxobutyrate CoA ligase, belongs to the small sub-group of PLP-
dependent enzymes which catalyse the condensations between amino-acids and CoA 
thioesters, with concomitant decarboxylation. 
The x-ray crystal structures for the apo- and PLP-bound forms of AONS from E. coil 
have recently been determined to 1.65 A resolution by workers in our group 72 
Figure 45 : Monomeric structure of AONS 
The active form of the enzyme is a homodimer, with each monomer consisting of 
three subunits. There is a small N-terminal (blue) domain linked to a central (major) 
) 
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domain (purple) which consists of a seven-stranded 13-sheet. The sheet is flanked by 
two a-helices, and is curved around two more. This is joined to a C-terminal domain 
(yellow) comprising of approximately 100 residues (see figure 45). 
The overall structure can be likened to an open left hand, with the thumb representing 
the N-terminal helix, and the fingers being the a-helices of the central domain. The 
rest of the N-terminal domain and the C-domain form the ball of the thumb and the 
heel of the hand, with the remainder of the palm and the fingers being the central 
domain. The N-terminal a-helical "thumb" lies on top of the a-helical "fingers" of the 
opposite monomer of the dimer forming an "intermolecular strap" (see figure 46). 
Figure 46: The active, dimeric form of AONS 
The PLP cofactor is attached to Lys236 located at the base of a deep cleft, which 
allows space for the pantotheinate arm of CoA to be admitted. A cluster of positively 
charged residues at the entrance to this cleft, near the centre of the dimer, forms the 
putative diphosphate binding site for CoA. 
Although AONS has a low overall sequence homology with the catalytic domains of 
the other a-oxoamine synthases, there are a number of key residues, which have been 











these are His133, Glu 175, Asp204, His207, Lys236 and Tyr264). This suggests that 
the organisation of the conserved catalytic residues within the active site is similar for 
all the enzymes of this sub-class of the PLP-dependent enzymes, and they share a 
common mechanism. 
Modelling studies72 have shown that the Ca proton of the PLP-Ala external aldimine 
points towards Lys236, which can move between C4' and the phosphate group of 
PLP, suggesting that it may be the residue that carries out the deprotonation. The 
acyl-CoA must then approach from the opposite si-face of the first quininonoid 
intermediate. Subsequent decarboxylation to give the second quinonoid intermediate 
may be assisted by PLP or the 0-ketone. The final protonation must then occur from 
the re-face of the complex to achieve the observed stereochemistry (see figure 47). 
This scheme is in accordance with the the mechanism suggested by Ploux e/ a! 78  for 
AONS, and with the mechanisms of other related PLP-dependent enzymes. 157 
Figure 47 : Proposed AONS mechanistic scheme 
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At this moment the structure of the alanine-PLP (external) aldimine bound in the 
active site of AONS has not been resolved. However, the x-ray crystal structure of 
AONS with synthesised AON in the binding site has recently been solved 157  (see 
figure 48). As in the internal aldimine structure, His133 adopts a position parallel to 
the pyrimidine ring system creating an important it-interaction, as well as forming a 
H-bond with the ketone oxygen of AON. Arg2 1 anchors the carboxylate tail of AON 
firmly with two hydrogen bonds. Ser179 and His207 are both hydrogen bonded to 
the 03' of the pyridoxal phosphate, which is in turn hydrogen bonded to the iminium 
nitrogen. 
Figure 48: AONS with AON bound in the active site 
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Chapter Three 
The Development of Synthetic Routes to Inhibitors of AONS and DANS 
55 
3.1 Enzyme Inhibition 
Generally, an enzyme inhibitor may be regarded as an agent that decreases the rate of 
an enzyme-catalysed reaction. Broadly speaking, enzyme inhibitors may be divided 
into those which are competitive (and usually, though not always reversible), and 
those which are non-competitive (and generally irreversible). 159 
The competitive inhibitors may be subdivided into the transition-state analogues, and 
the slow, tight binding inhibitors, although there is a significant amount of overlap 
between these two classes. 
Transition-state analogues are compounds that have a structure that closely resembles 
the conformation of a substrate at a postulated transition state, or a transient species 
in the enzyme catalysed pathway. The basis for the design of such a molecule lies 
with the hypothesis 160,161  that an enzyme achieves its great rate enhancements by 
changing its conformation in such a way that the strongest interactions occur between 
the substrate and the active site residues at the transition state of the reaction. This 
implies that an analogue which has a structure similar to the transition state should 
bind more tightly than the substrate in the ground state. 
Slow, tight binding inhibitors are compounds which either induce a conformational 
change in the enzyme leading to an extremely tight interaction, or compounds that 
form slowly reversible covalent bonds within the enzymatic active site. 
The non-competitive (and predominantly irreversible) inhibitors may be broadly 
placed into two classes; the affinity labelling agents, 159  and the mechanism-based 
enzyme inacivators (suicide inhibitors). 162 
Affinity labels are compounds that contain a reactive functional group, and react with 
an active site residue forming a covalent bond, resulting in the irreversible inhibition of 
the enzyme. They may be fairly non-specific in action, undergoing reaction with more 
than one residue and / or protein. However, by making the structure closely resemble 
the natural substrate, a greater level of specificity may be obtained. These type of 
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compounds often contain an a-haloketone, azide or isocyanate moiety, and 
consequently react with nucleophilic residues such as lysine, cysteine, or serine in the 
active site. 
A mechanism-based enzyme inactivator is a relatively unreactive compound, having a 
structural similarity to the substrate or product for a particular enzyme that, via its 
normal catalytic mechanism of action, converts the inactivator into a species which, 
without prior release from the active site, binds covalently to the enzyme. 
The ability of the PLP-Schiff bases to stabilise negative charges at the a—,13—and y—
carbon atoms of the substrate has been used in the rational design of a wide range of 
substrate analogues that have inhibitory properties. Generally, the approach taken has 
been to incorporate moieties into the substrate molecule which, through the normal 
catalytic mechanism, generate reactive electrophilic intermediates which react with 
proximal, nucleophilic active site residues. This leads to the formation of a covalent 
bond between the substrate analogue and the enzyme causing irreversible inhibition. 
The most common groups which are adventitiously incorporated into the natural 
substrates to create these reactive conjugated imines, ketimines, or allenes are; olefins, 
acetylenes, halogens, nitriles and azides amongst many others. 	Fluorinated 
compounds have been utilised extensively in the synthesis of PLP-dependent enzyme 
inhibitors, as the nature of the C-F bond favours elimination reactions rather than SN2 
displacements. Also the van der Waal's radius of fluorine (1.35A) is very close to 
that of hydrogen (1.20A), making steric factors relatively unimportant. 163 
A number of compounds were identified as potential inhibitors of AONS; these being 
either structural analogues of AON (8), or the putative carboxyl intermediate in the 
condensation 51 (as shown in figure 49). 
NH3 	 'NH3 
H3C7 __. 
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Figure 49: AON and its putative enzymatic precursor 
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3.2 The Use of Schiff-Bases in the Synthesis of (±)-AON and Related 
compounds 
3.2.1 The Use of Schiff-Bases in the Synthesis of Amino-Acids 
Schiff-bases have been utilised extensively in the synthesis of non-proteinogenic 
amino-acids,164 and consequently it was thought that this methodology could be 
adapted for the synthesis of analogues of 8 and 51. 
The vast majority of Schiff-base chemistry, pioneered by Phillipe Bey, Martin 
O'Donnell and Gilbert Stork, concerns the use of benzophenone ketimines, and 
benzaldehyde aldimines of amino acids and related compounds. The published 
chemistry in this area is almost entirely restricted to alkylations16567  and Michael 
additions,168 and only one reference to an acylation could be located,169 which 
coincidentally was in the synthesis of an inhibitor of sphingosine-1-phosphate lyase, 
another PLP-dependent enzyme. 
Benzophenone and benzaldehyde-derived Schiff-bases such as 52 and 53 respectively 
may be deprotonated using a variety of organic bases, such as LDA,'65 DBU,168  
potassium t-butoxide'66 and sodium hydride, 170  at low temperature to generate the 
corresponding aza-allylanions 54 and 55 (see figure 50). The presence of electron 
withdrawing groups, such as -CN, or CO2R adjacent to the a-proton(s), results in 
negligible reactivity at the imidic-carbon position, 171  when the aza-allylanions of 
Schiff-bases such as 54 or 55 are reacted with electrophiles. 
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Figure 50: Benzophenone and benzaldehyde imines 
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3.2.2 Phase Transfer Catalysis 
As the aromatic Schiff-bases of amino acids (and their cyano analogues), are 
moderately base-stable and have cc-protons with acidities between pKa = 16 and 
23,164 they are ideally suited to reactions involving phase transfer catalysis. 
Consequently, a wide variety of alkylation 172,173  and Michael addition 174  reactions 
with Schiff-bases, under PTC conditions have been reported in the literature as routes 
to non-proteinogenic amino-acids and related analogues. 
Phase-transfer catalysis (PTC) enables anions, or reactive species in one phase 
(aqueous or solid) to react efficiently with substrates soluble in a separate, organic 
phase. These bi-phasic processes are mediated by phase transfer catalysts, usually 
quaternary ammonium or phosphonium salts, or crown-ethers, which facilitate the 
exchange of charged species between the phases. 
In hydroxide ion-initiated phase transfer catalysis 175  (PTC/OH), one of the phases is 
an aprotic solvent, such as toluene or dichiorornethane, and the other phase is an 
alkali metal salt (e.g. finely ground KOH, or K2CO3), or a concentrated basic solution 
(e.g. 50 % aq. NaOH). In contrast to the standard anhydrous techniques involving 
organometallic reagents, PTC/OH reactions can generate the substrate anion under 
mild, basic conditions and do not necessarily require an inert atmosphere. 
There is extensive kinetic data to suggest that aromatic Schiff-bases react via an 
interfacial mechanism. 175  A substrate molecule in the organic phase, located near the 
interface, is deprotonated by a hydroxide ion proximally positioned in the aqueous (or 
solid) phase, forming a metal cation-carbanion ion-pair at the interface [WW]. 
Exchange of the metal cation, with the cation of the quaternary (ammonium) salt, 
forms a lipophilic ion pair [QR] (with concomitant release the metal-halide salt into 
the other phase) allowing the transfer of the carbanion into the bulk of the organic 
phase where it may react. A schematic for the alkylation of a Schiff s-base using 
PTC/OH is shown in figure 51. 
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Figure 51: Schematic diagram showing the interfacial mechanism in PTC 
reactions 
3.2.3 An Investigation into the Acylation of Schiff-Bases 
It was thought that by reacting aromatic Schiff-bases with a variety of acylating 
species under organic-base and I or PTC conditions, a selection of efficient, robust 
and general routes to a-oxoamines could be developed. The general strategy is 
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Figure 52 : General strategy for the synthesis of a-oxoamines 
The benzophenone ketirnines 57 and 58 were prepared in high yield via transimination 
reactions between benzophenone imine (56) and the hydrochloride salts of L-alanine 
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Figure 53 : Preparation of the starting imines 
Imine 59 was synthesised under PTC, by the slow addition of methyl iodide to a 
rapidly stirring, ice-cooled mixture of 58 in toluene / 50 % aq. NaOH, using benzyl 
triethylammonium chloride (BTEAC) as a catalyst. 172  This general procedure has 
been shown to give predominantly mono-alkylated product when one equivalent of 
alkyl halide is used, due to the Ca. 1000 fold reduction in acidity of the cI-proton in 
the product compared with the starting material. 164 
To investigate whether or not acylation was feasible under PTC conditions, a number 
of trial reactions were performed using the benzophenone imines 58 and 59, and a 
61 
selection of acid chlorides as shown in table 1. BTEAC was used for all the PTC 
reactions in a 0.1 molar equivalent, as this has been shown to be effective in both 
toluene / aqueous base, 172  and solid-liquid PTC mixtures. 174  The system using 50% 
aq. NaOH (3 molar eq.) I toluene (in equal volume to the basic solution used) and 
BTEAC (0.1 molar eq.) is the PTC method most widely used in the alkylation of 
benzophenene imines, and hence was used as the starting point for the acylation trials. 
As table I shows, the acylation of 59 with acetyl chloride was not successful and only 
the starting irnine was recovered upon workup. The attempted acylation of 58 with 
pivaloyl chloride, and with the acid chloride of mono-ethyl pimelate (60) was similarly 
unsuccessful. 
Imine Acylating agent Phase-Transfer Conditions Product 
59 acetyl chloride 1.3 eq. 50% NaOH (3 eq.)/ Toluene/ No reaction 
BTEAC (0.1 eq.) / RT / overnight 
58 pivaloyl chloride 1 eq. 50% NaOH (3 eq.) / Toluene / No reaction 
BTEAC (0.1 eq.) / RT / overnight 
58 60 1 eq. 50% NaOH (3 eq.) / Toluene / No reaction 
BTEAC (0.1 eq.) / RT / overnight 
Table 1 
In all of these reactions the formation of the ketimine anion was observed, as the 
biphasic mixture of the imine, phase-transfer catalyst, toluene and aq. NaOH was a 
deep red colour before the acid chloride was added. The inability of these acid 
chlorides to acylate the benzophenone ketimines can be ascribed to the competing 
hydrolysis reaction, or the unreactivity of the imine anions towards the acylating 
species. 
To reduce acid chloride hydrolysis during the course of the reaction, non-aqueous 
solid-liquid PTC conditions with BTEAC and K2CO3 as a base were employed as 
shown in table 2. 
62 
Imine Acylating agent Phase-Transfer Conditions Product 
58 acetyl chloride 1 eq. K2CO3 (0.5 eq.) / BTEAC (0.1 eq) / 61(32%) 
sonication for one hour at 45 °C 
58 pivaloyl chloride 1 eq. K2CO3(0.5eq.) / BTEAC(0. leq) / No reaction 
sonication for 2 hours at 45 °C 
58 pivaloyl chloride 5 eq. K2CO3  (1 eq.) / BTEAC (0.1 eq) / No reaction 
sonication for 3 hours at 60 °C 
59 pivaloyl chloride 1 eq. K2CO3 (0.5 eq.) / BTEAC (0.1 eq) / No reaction 
sonication for 2 hours at 45 °C 
57 60 2 eq. K2CO3 (0.75 eq.) / BTEAC (0.1 eq) / No reaction 
sonication for 4 hours at 60 °C 
57 60 2 eq. K2CO3 (0.75 eq.) / BTEAC (0.1 eq) / No reaction 
acetonitrile /sonication for 4 hours at 
60°C 
Table 2 
When one equivalent of acetyl chloride was added to a mixture of imine 58, finely 
ground anhydrous K2CO3 (0.5 eq.) and BTEAC (0.05eq.), and was sonicated for one 
hour at 45 °C, only one product, tentatively assigned as 61, was formed (32 % yield, 
mixture of cis and trans forms) i.e. there had been a re-acylation of the enolised form 
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Figure 54 : The formation of 61 
However, the reaction of imines 58 and 59 with pivaloyl chloride failed to generate 
detectable amounts of any acylated product, possibly due to steric inaccessibility. The 
63 
reaction of 58 with 60 (2 eq.) with, or without the presence of acetonitrile as solvent, 
also failed to yield any of the desired products. 
Since phase transfer chemistry failed to yield any of the desired results, benzophenone 
irnine acylations using standard anhydrous techniques were attempted (see table 3). 
Imine Acylating agent Reaction conditions Product 
57 62 1.3 eq. TI-IF / LDA -78°C Transesterification 
59 acetyl chloride 1.5 eq. DBU (1.2 eq)/ DMAP (0.1 eq.) / 
-78°C to RT 
No reaction 
58 60 2.5 eq. TI-IF / LDA -78°C to RT 66(25%) 
58 60 1 eq. THF /LDA -78°C to RT 66(17%) 
57 65 1.5 eq. THF / LDA -78°C to RT No reaction 




The Weinreb amide176 of ethyl hydrogen pimelate 62 was prepared in good yield by 
the condensation of 60 with N,O-dimethyl hydroxylamine hydrochloride in the 
presence of excess pyridine (see figure 55). The thiophenol ester of methyl hydrogen 
pimelate (65) was prepared in two different ways; either by the addition of an ethereal 
solution of diazomethane to the thiophenol ester 32, or by the reaction of the acid 
chloride of methyl hydrogen pimelate (64) with 1.5 eq. of thiophenol, using 
triethylamine to remove the HC1 produced (as shown in figure 56). 
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Figure 55 : The preparation of 62 
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Figure 56 : Two synthetic routes to 65 
When 62 was added to the lithium-anion of 57, transesterification ensued, and the 
ethyl ester of the imine and the methyl ester of the Weinreb amide were isolated as the 
major products, and no acylation was observed. DBU and DMAP were incapable of 
catalysing the acetylation of 59 under the conditions employed. When 2.5 eq. of 60 
was added to the LDA-derived anion of 58 at -78 °C, 66 was formed as the major 
product (m/z: 561 (MILl), 391 (M-C9H1403 ), presumably via an analogous 
mechanism to 61 as shown in figure 57. However, when the ratio of the acid chloride 
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Figure 57: The formation of 66 
There was no observed reaction when the thiophenol ester 65 was added to the 
lithiated azaallyl anion of 57 when TI-IF, or TI-IF / HIVIIPA solvent mixtures were used. 
As conditions which would lead to the mono-acylation of the benzophenone imines 
could not be found, the chemistry of the benzaldehyde aldimines was investigated. 
PhYH 	 Ph . _H 	 Ph 1 H 
N 	 N 	 N 
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Figure 58: Benzaldehyde aldimines 
65 
The aldimines 67 and 68 were prepared in high yield via the dehydrative condensation 
of benzaldehyde and the hydrochloride salts of alanine methyl ester and 
aminoacetonitrile respectively. 166  The aldimine 69 was prepared in 55 % yield by the 
slow addition of a molar equivalent of methyl iodide to the lithiate of 68 at -78°C. As 
found by O'Donnell 164  there was a significant amount of the di-methylated species 
formed (35%) due to 68 and 69 having roughly similar pKa values (Ca. 18). 
The benzaldehyde aldimine of L-alanine methyl ester (67) was subjected to a variety 
of different acylation agents, using LDA and PTC to generate the azaallyl anion (as 
shown in table 4), to ascertain whether mono-acylation was possible. 
twine Acylating agent Reaction conditions Product 
67 acetyl chloride 2 K2CO3 (0.5 eq.) / BTEAC (0.1 Starting materials + 
eq. eq) / sonication / 50 °C/ 5 hours mixture of products 
67 60 1.1 eq. K2CO3 (0.5 eq.)! BTEAC (0.1 No reaction 
eq.) / sonication / 50 °C! 6 
hours 
67 acetyl chloride LDA! THF! -78 °C to RT No reaction 
1.1 eq 
67 70 1.2 eq LDA! THF / -78 °C to RT No reaction 
67 71 1.2 eq LDA! THF / -78 °C to RT No reaction 
67 60 2.5 eq LDA / TI-IF / -78°C to RT! 72(42%) 
inverse addition 
67 652.5 eq LDA! TI-IF! -78°C to RT! 72(17%) 
inverse addition 
Table 4 
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Figure 59: Preparation of the acylating agents 70 and 71 
The solid-liquid PTC reaction between acetyl chloride and 67 generated a complex 
mixture of products that could not be separated nor identified, as well as unreacted 
imine. The analogous reaction with 67 and 60 was also unsuccessful. N-methoxy-N-
methyl acetamide (70) has been shown to be an effective acetylating agent for a 
number of strongly basic and nucleophilic enolate anions. 177  The amide 70 was 
prepared in a similar manner to 62 from acetyl chloride and N,O-dimethyl 
hydroxylamine hydrochloride (see figure 59). The thioester 71 was synthesised by the 
addition of thiophenol and excess triethylamine to a cooled solution of acetyl chloride. 
TI-IF solutions of the three acetylating agents, acetyl chloride, 70 and 71 were added 
to the LDA-generated anion of 67 in TI-IF at -78 °C, and the reactions were allowed 
to slowly warm to room temperature overnight. However none of these three 
reactions afforded any addition products (only starting materials were recovered). 
Reverse addition is a method commonly used to prevent the over-reaction of the 
initially formed (reactive) product. In this method, the anion is added to a several-
fold molar excess of the alkylating or acylating compound, resulting in a rapid quench 
of the charged species, and reducing the likelihood of the product reacting further. It 
was thought that this approach might be more successful than the normal-addition 
method (i.e. the addition of the alkylating or acylating species to the anion) which had 
been employed in all the previous imine acylation reactions. 
Consequently, a solution of the azaallyl-anion of 67 at Ca. -40 to -50 °C was added 
slowly, via canula to solutions of the acid chloride 60 and the thiophenol ester 65 in 
THF at -78 °C, which were then allowed to react whilst warming to room 
temperature overnight. Aqueous workup and subsequent purification of the crude 
organic extracts yielded the desired product 72 as a pale yellow oil, in 42 and 17 % 
yields respectively. The ketone 72 was slightly unstable to decomposition on silica- 
67 
gel, and was thermally unstable (having an estimated half-life of Ca. 3 days in 
deuteriochioroform at room temperature). The identity of the product was confirmed 
by 'H NIvIR and mass spectrometry. This was further confirmed by the acidic 
hydrolysis of 72, which yielded, after purification by ion-exchange chromatography, 
the hydrochloride salt of (±)-AON as the main product. 
The ability of the thioester 65 to successfully acylate the Schiff-base 67 means that, in 
effect an overall biomimetic synthesis of AON has been achieved (see figure 60). As 
in the AONS catalysed process, the first step is the formation of a Schiff-base between 
alanine and an aromatic aldehyde. The second process is a proton abstraction, and 
subsequent acylation with a thioester of pimelic acid. 	The final step is a 
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Figure 60 : Biomimetic synthesis of (±)-AON 
It can be concluded from these experiments that the acid chlorides are the most 
effective acylation species, and that inverse addition of the azaallyl imine anions to the 
acylating agent is crucial for the success of the reaction. Further investigation is 
required to demonstrate whether or not Weinreb amides and other carboxyl activating 
(protecting) groups are compatible with this inverse-addition procedure. It also 
remains to be seen whether the benzopheneone imines, and the cyano-aldimines 68 
and 69 can be selectively mono-acylated using this methodology. 
3.3 The Use of Dakin-West Chemistry in the Synthesis of (±)-AON and 
Related Compounds 
3.3.1 The Dakin-West Reaction 
In 1928 Dakin and West178 developed a method for the conversion of an ct-amino 
acid into the corresponding ct-acetylamino-alkyl methyl ketone, by the action of acetic 
anhydride in the presence of pyridine. Further investigations' 79,180 demonstrated 
that carbon dioxide was evolved during the course of the reaction, and that other 
bases such as alkylpyridines and sodium acetate could replace pyridine. The reaction 
was shown to be applicable for other acid anhydrides, although in general the yields 
reduce significantly with increasing chain length (see figure 61). 
H2NCH(R)CO2H 	J0. RCON}ICH(R)COR' + CO 2 
Figure 61: The Dakin-West reaction 
Dakin and West179 also postulated the intermediacy of an oxazol-5-one 73 in the 
reaction course, and demonstrated that these compounds yielded the same product as 
their parent amino-acid. Subsequent studies'81"82 have borne out this contention, 
and a general mechanism is shown in figure 62. Kinetic measurements have shown 



















R111, NH + RCO2H 













0 	 0 
Figure 62 : Mechanism of the Dakin-West reaction 
More recent research has shown that the replacement of pyridine with the acylation 
catalyst DMAP'83 '84 can greatly enhance the reaction rate, resulting in better yields 
at lower reaction temperatures. Further work by Steglich and Hofle185 -188 has led 
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Figure 63 : The 'stepwise' Dakin - West procedure 
In the 'stepwise' reaction scheme, the oxazol-5-one 73 is pre-formed, and is reacted 
under mild conditions (room temperature or below) with an acid chloride in the 
presence of triethylamine. This leads to the kinetic 0-acyl product 74 being formed, 
which slowly isomerises to the more stable C-acyl, thermodynamic product 75.185 
The 0-acyl product can be isolated, or may be isomerised in situ by the addition of a 
catalytic amount of DMAP (which has been shown to be more efficient than pyridine 
and other bases). 183,184 
Using 'H-NMR experiments, Steglich and Hofle'86 have demonstrated the 
intermediacy of a species (76) in the isomerisation process which disappears with the 
concomitant formation of the C-acylated product 75. Consequently, the authors have 
proposed that the acyl migration occurs via the formation of the ion-pair 77, which 
may equilibrate with the dihyrdopyridine-condensed species 76, to give the 
thermodynamic C-acylated product 75 (see figure 64). It is noteworthy that under 
standard Dakin -West conditions, the 0-acylated product has never been observed. 
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Figure 64: Mechanism of acyl migration 
Thus the 'Stepwise' Dakin-West procedure appeared to be a viable and versatile route 
to the synthesis of (±)-AON and related compounds. It was decided to evaluate this 
possibility. 
3.3.2 The Synthesis of (±)-AON using Dakin-West Chemistry 
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Figure 65 : A route to AON using Dakin-West chemistry 
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N-Benzoyl-L-a!anine (78) was prepared from L-alanine in high yield by a standard 
Schotten-Bauman procedure 189 using 2M NaOH and benzoyl chloride at 0 °C. The 
synthesis of the oxazol-5-one 79 was achieved via the dehydrative self-condensation 
of the mixed anhydride formed between 78 and acetic anhydride190 (see figure 66). 
This latter procedure was adopted, rather than a carbodiimide-activated route,191 
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Figure 66 : Oxazol-5-one formation 
Optical rotation measurement confirmed that complete racemisation had occurred 
during the oxazolone ring formation step (the melting point of N-benzoyl-L-alanine 
(78) corresponded closely to the literature value192 of 150-151°C, and the melting 
point of oxazolone 79 (35-37 °C) was in agreement with the literature value of 37- 
39°C193 for the racemate). 
The triethylamine-catalysed condensation of oxazolone 79 and acid chloride 60 was 
performed analogously to the procedure described for the acetylation of 79 by 
Steglich and Hofle,'85 except that in this case the reaction was maintained at 0 °C for 
3 hours, then stirred at ambient temperature for 18 hours. After aqueous workup and 
purification by silica-gel chromatography, the desired product 80 was obtained in 84% 
yield as a colourless oil. 
Isomerisation of the 5-acyloxazole 80 to the 4-acyloxazolone 81 was achieved in 
moderate yield by stirring a solution of 80 in THY with a 3% molar equivalent of 
DMAP overnight at room temperature. Longer reaction times led to a greater degree 
of conversion from the 0- to the C-Acyl product, but this was accompanied by slow 
thermal decomposition of the desired product, leading to lower overall yields being 
72 
obtained. The thermodynamic product 81 appears to be less thermally stable than the 
kinetic product 80 (with an estimated half-life in deuteriochloroform of Ca. 1 week at 
room temperature). For this reason it was decided to examine a one-pot, hydrolytic 
oxazolone ring-opening, de-esterification, decarboxylation and de-benzoylation 
procedure under acidic conditions, as an alternative. 
The desired product (±)-AON (hydrochloride salt) was obtained in moderate yield 
(36% after purification), by vigorously stirring the oxazolone 81 in 4M aqueous HC1 
at 80 °C overnight. The main by-products formed (identified by a combination of tic 
and 'H-NMR) were alanine, N-benzoyl alanine, pimelic acid, and mono-methyl 
pimelate. All of these could be removed by repeated extraction of the acidic product 
solution with chloroform, except alanine, which could be separated in the final ion-
exchange purification. 
The formation of these products is consistent with hydrolytic attack at the ketonic 
carbonyl (pathway 1 in figure 67) competing with the desired hydrolysis at C-S of the 
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Figure 67 : Acidic hydrolysis of 4-acyl-oxazol-5-one (81) 
73 
Similar findings have been reported for the hydrolytic ring opening of more simple 4-
acyloxazol-5-ones to the corresponding N-benzoyl-amino ketones, with analogous 
results also obtained for aminolysis and methanolysis.'87  
In brief conclusion, this route has been shown to be successful for the synthesis of 
(±)-AON, but more work will be required to develop this pathway for the synthesis of 
AON analogues. 
3.3.3 Considerations for Future Development of the Strategy 
It has been noted previously187191  that heating the 4-acyloxazol-5-one with pyridine 
and acetic anhydride, or oxalic acid can effect a mild and non-hydrolytic, 
decarboxylative ring opening with minimal reaction at the ketone carbonyl. However, 
the application of this method for the ring-opening of 4-acyloxazol-5-one 81 remains 
to be investigated. 
The potential use of this route for the synthesis of the putative carboxylated 
intermediate in the b/oF catalysed process (51) was considered. 
There is a possibility that the oxazolone 81 could be hydrolysed under mild conditions 
to the ct-acyl-a-(N-benzoyl)-amino-acid 82. However the harsh (acidic) conditions 
required to remove the N-benzoyl group would probably lead to an (acid catalysed) 
J3-decarboxylation, resulting in the formation of (±)-AON (8). This might be avoided 
if the ketone functionality was protected as a dithiolane, or dithiane,'45 prior to the 
acidic benzoyl removal step. The dithioacetal protection could then be removed in a 
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Figure 68 : Proposed route to (:E)-51 
3.4 A route to an Affinity Labelling  Agent for DANS (AONS) 






Figure 69: (S)-AON and affinity label analogue (83) 
Species 83 can be proposed as a plausible candidate for an affinity reagent, which may 
inactivate DANS (and I or possibly AONS). As with the natural substrate, AON (8), 
the target compound 83 contains a nonanoic acid carbon backbone and has a ketone 
functionality at the C-7 position, and is therefore capable of forming an external 
aldimine with the PMIP-cofactor in the enzyme active site. 
The a-bromoketone 83 has an analogous structure to bromopyruvate, which Morino 
and Okamoto1 95,196  have shown to be a slow inactivator of pig heart aspartate 
aminotransferase. This affinity reagent may react with an active site nucleophile, e.g. 
the lysine residue involved in forming the internal aldimine with the PLP cofactor, 
75 
resulting in enzyme alkylation as shown in pathway (a). Alternatively there is also the 
possibility that 83 may form a Schiff-base with the PMP (present in DANS) leading to 
enzyme alkylation via a Michael type attack from an active site nucleophile following 
the elimination of a bromide ion, as shown in pathway (b). 
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Figure 70 : Possible mechanism of DANS inhibition 
The alcohol 41, the by-product from the reductive amination of ketone 39 in the 
dithiolane synthetic pathway (see figure 36), appeared to be a good starting material 
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Figure 71: Proposed route to the affinity label 83 
However when the bromination of 41 was attempted using triphenyiphosphine / 
bromine197 in DCM at 0 °C, the major product obtained (75 %) was not the desired 
product 84, but a rearranged product 85. Possible mechanisms for this rearrangement 
are shown in figure 72. 
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Figure 72 : Possible mechanisms for the formation of 85 
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Donatelli and Chen 214  and Lee et al. 215  have reported that 2,2-disubstituted- 1,3- 
dithiolane mono-sulfoxides can undergo an analogous rearrangement under acidic 
conditions to give the corresponding 2,3 -di substituted- 5,6-dihydrodithiines. (see 
figure 73). 
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Figure 73: Formation of 2,3-disubstituted dithiines 
Rubinstein and Wuerthele216 have demonstrated that 2,3-disubstituted-5,6-
dihydrodithiines are also formed when a-bromoketones are reacted with ethane-1,2-
dithiol under acid conditions with the azeotropic removal of water. 
An alternative three step route to 83 would be to remove the dithiolane moiety prior 
to the bromination process, and saponification. However, when the hydroxy 
compound 41 was treated with NBS at -5 °C in 80 % aqueous acetonitrile; conditions 
similar to those employed in the dithiolane deprotection previously used in the 
synthesis of(+)-AON, the main product obtained was the disulfoxide 87 (68 %), and 
the desired a-hydroxy ketone 86 was only isolated in 27 % yield (see figure 73). It 
may be noted that the dithiolane protecting group was removed in 94 % yield from 
the analogous amine 40 using an identical procedure. 
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Figure 73 : Disulfoxide formation 
A number of authors have reported that stoichiometric amounts of Cl'(generated in 
situ from iodobenzene dichloride 217  or 1-chlorobenzotriazole218'219 in either aqueous 
acetone or acetonitrile) can selectively oxidise 1,3-dithiolanes to the corresponding 
mono- or Ji-suifoxides within minutes at 0°C. Prolonged reaction times and higher 
temperatures were found to result in further oxidation to give di-sulfones. 
With this anomalous sulfur oxidation occurring in competition with the dithiolane 
deprotection of 41, it was conjectured that this might be minimised if the hydroxyl 
was derivatised. The protecting group could then be removed afterwards to allow 
bromination of the hydroxylated compound, which could be saponified to give the 












Figure 75: Second proposed route to 83 
Since an insufficient amount of the alcohol 41 was available (as a by-product of the 
reductive amination of 39 using the one-pot, ammonium acetate procedure) it was 
synthesised in 98 % yield by the reduction of ketone 39 with NaBH4 in ethanol / DCM 
at room temperature. This compound had identical NMIR characteristics, and co-
eluted on tic with the material previously obtained. The alcohol 41 was converted in 
high yield (94 %) to its acetate derivative 88 by reaction with excess acetic anhydride 
in pyridine. Unlike compound 41, the dithiolane group of 88 was efficiently removed 
by NBS in aq. acetonitrile (as performed previously), to give the ketone 89 in 89 % 
yield. This implies that the Br-mediated removal of the dithiolane moiety from 88 
occurs more quickly than for 41, and consequently there is less time for the slower 
sulfur oxidation process to take place. 
Regrettably, lack of material and the preferential pursuit of other synthetic targets has 
meant that this route has not been taken any further. 
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Chapter Four 
The Inhibition of Dethiobiotin Synthetase 
E:I 
4.1 The Formation of the Ureido ring of Dethiobiotin 
Recent work in our laboratory 198 has shown that the binding of the terminal methyl 
group plays an important role in the DTBS-catalysed reaction. Comparison of the 
crystal structures of the amino-carbamate 18, and DTB bound to DTBS has revealed 
that the enzyme affects a change in conformation of the bound DAN-
carboxyphosphate intermediate 25 to set-up the correct geometry for the ureido ring 
closure. There is a Ca. 60 ° rotation around the C7-C8 bond which places the methyl 
moiety in a new hydrophobic binding pocket (see figure 76). The nature of the 
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Figure 76 : The role of the methyl group in the ureido ring closure reaction 
IM 
4.2 The Synthesis of a Potential Inhibitor of Dethiobiotin Synthetase 
In the past, phosphate esters have been identified as prototypes for the design and 
synthesis of analogues that would posses modified chemical, and hence biological 
properties. 199 In general, most attention has been placed upon the isosteric 
replacement of either an internal, or an external oxygen atom of the phosphate, with 
nitrogen (X = NR'), sulfur (X = S) or methylene (X = CH2) functions (see figure 77). 
Internal oxygen substitution leads to the phosphoramidate 90, thiolphosphate 91 and 
phosphonate 92 analogues. These substitutions preserve the general ionisation 
pattern of the parent phosphate monoester, without leading to a large difference in the 
geometrical arrangement around the phosphorus centre. 
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External oxygen replacement 
0 	 0 	 0 
OH 	 Uri 	 Uri 
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Figure 77 : Phosphate ester analogues 
Amongst examples of phosphonate analogues of phosphate esters that have found 
practical applications are i) the insecticide trichiorfon (93), ii) the weedkiller 
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Figure 78: Commercially used phosphonate compounds 
The phosphonate isostere 96 of the mixed anhydride species 25, the proposed 
intermediate in the penultimate step of biotin bio synthesis, 93'94 was identified as a 
target compound (see figure 79). 96 should adopt a conformation similar to 25 in the 
binding site of DTBS, but due to the methylene incorporation, would be unable to 
undergo an internal phosphate displacement. If there was a strong non-covalent 
interaction between 96 and the enzyme, as may be postulated for a short-lived 
enzymatic intermediate, then the compound would be expected to reversibly inhibit 
the enzyme. 
If this was shown to be the case, then 96 could be catagorised as a transition state 
analogue. 200 
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Figure 79 : The postulated DTBS enzymatic intermediate and isosteric analogue 
The amine 40, an intermediate from the dithiolane-based AON synthesis, should be a 
good starting point for the synthesis of 96, as it contains a mono-protected 7,8-
difunctional moiety. The general strategy here was to protect the primary amine at 
the C-8 position, and then convert the 7,7-(ethylenedithio)-group to an amine, which 
could be coupled to a protected phosphonoacetate compound. The formed 
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Figure 80 : Proposed synthesis of the intermediate-isosteric analogue (96) 
The amine 40 was converted to its N-benzyloxycarbonyl derivative 97 in 88 % yield, 
using benzyl chioroformate. Deprotection of the dithiolane compound 97 was 
performed as before, to give the ketone 98 in high yield. The reductive amination of 
98 was initially performed using the one-pot, ammonium acetate I NaCNBH3 
procedure used previously. However as found in the synthesis of 40, the yields of this 
reaction were both modest and variable, and competing ketone reduction occurred. 
When the HAMS I TiC14 two-step reductive amination procedure was used, 99 was 
formed in 51 % yield and no alcohol formation was observed. 
Whilst the reductive amination of ketone 39 generates a racemic product 40, the 
analogous reaction with the prochiral ketone 98 results in the formation of two 
diastereomers. Examination of the 'H NMR spectrum of the product indicated that it 
contained both diastereomers in a 1: 1 ratio. This was clear from comparison of the 
integrals for the doublets at 1.04 and 1.14 ppm, corresponding to the two C-9 methyl 
protons of the diastereomeric mixture. This ratio was constant for both of the 
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Figure 81: The diastereomeric amines formed 
Although both of the diastereomeric amines 104 and 105 (see figure 81) were 
identical on tic, they proved separable by adsorption column chromatography on 
silica-gel, eluting with a gradual DCM I methanol gradient. Diastereomer (a) eluted 
first (C-9 methyl doublet at 1.14 ppm, amido NI-I resonance at 5.18 ppm, C-8 at 54.7, 
urethane C=O at 156.1) followed by diastereomer (b) (methyl doublet at 1.04, NI-I at 
5.27, C-8 at 54.8, urethane C=O at 155.8). At 250 MHz, the signals at 2.7 and 3.8 
ppm on the 1H NIVIIR spectrum, corresponding to the C-7 and C-8 methyne protons 
respectively, were unresolved for both diastereomers (a) and (b). 	Selective 
decoupling experiments at 600 MIl-Iz also failed to resolve these resonances clearly 
enough to obtain any of the coupling constants for these protons. 
However, separation of the diastereomers was far from quantitative and only small 
amounts of pure material could be separated. For this reason it was decided to 
continue with the next step of the synthesis using a mixture of the diastereomeric 
amines - with the hope that subsequent diastereomeric mixtures would prove more 
tractable to separation 
The peptide coupling was initially performed using dicyclohexylcarbodiimide (DCC) 
as the activating agent for diethyl phosphonoacetate. This afforded the desired 
product 101 in modest yield (34 %). The main problem with this procedure was the 
RD 
separation of the product from the dicycloheyl urea formed as a byproduct. The DCU 
also displayed similar solubility and chromatographic properties to 101 necessitating 
repeat chromatography of the initially obtained product. 
A diisopropylcarbodiimide (DIC) / 1-hydroxy-4-carbethoxytriazole (HOCt) coupling 
was then attempted in the presence of Hunig's base (diisopropylethylamine). This 
afforded 101 in higher yield (54 %), but again the urea biproduct proved difficult to 
remove from the product mixture. 
The use of the acid chloride of diethyl phosphonoacetate (100), in the synthesis of 101 
was tested by conducting a trial reaction with isopropylamine (see figure 82). 
Phosphono-amide 106 was formed cleanly, in good yield by the addition of 
isopropylamine to a solution of 100 in DCM at room temperature. 
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Figure 82 : Trial coupling reaction 
The purity of 100 was determined by 'H NMIR spectroscopy; observing the 
disappearance of the methylene signal for the acid at 2.97 ppm (2H, doublet, JPFI  22 
Hz), and the appearance of the methylene signal for the acid chloride 100 at 3.49 ppm 
(2H, doublet, Jpi 21.2). 
Development of this synthesis showed that the best results were obtained by the 
dropwise addition of excess triethylamine to a solution of amine 99 and a 2 molar 
equivalent of 100 (freshly prepared by reacting diethyl phosphonoacetate with 2 molar 
equivalents of oxalyl chloride), in DCM at ambient temperature. Using this 
procedure, 101 was formed in 70% isolated yield, without the previously encountered 
problems of urea contamination. 
The erythro and threo diastereomers of 101 were again only partially separable by 
silica-gel chromatography, so the use of reverse phase HPLC was investigated as a 
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means of purification. Although the compound could be cleanly separated from 
starting materials and by-products on a C8 column, the diastereomers proved 
inseparable. 
A large number of methods known for the removal of esters, ethers and urethanes, 
which are commonly used as protecting groups, involve the use of halide ions under 
non-hydrolytic conditions. 131'201203 It was thought that this would be the most 
effective method for the full deprotection of 101 under mild conditions. To avoid the 
unnecessary wastage of material, a trial reaction was first performed on the previously 
synthesised compound 106 (see figure 83) 
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Figure 83: Trial deprotection of 106 
Treating 106 with a 10 molar equivalent of bromotrimethylsilane (TMS-Br)201 in 
DCM at room temperature for 18 hours, resulted in formation of the deprotected 
phosphonate 108 in around 65-70 % yield, with the remainder of material being the 
mono-phosphonate ester 107 (by comparison of the integrals for the doublets at 2.70 
and 2.72 corresponding to the methylene protons of 107 and 108 respectively in the 
'H NMIR spectrum). 
Treatment of a solution of 101 in DCM, with a 20 molar equivalent of TMS-Br at 
35°C for 18 hours led to a mixture of three species being formed; the desired product 
96, its ethyl ester 110, and the mono-phosphonate ester 109 (see figure 84). The 
products were identified by a combination of 'H NMIR and mass spectroscopy [nilz 
310 (96), 338 (110) and 362 (109)]. The relative amounts present could not be 
accurately determined due to the superimposition of the signals corresponding to the 
diastereomeric phosphonate methylene protons at 2.70 ppm, and the phosphonate and 






















Figure 84 : The products from the TM S-Br deprotection of 101 
From these two experiments, it can be clearly seen that the ease of removal of the 
protecting groups is : N1-I-Cbz> P(0)OEt > C(0)OEt, which is in agreement with the 
findings of Lott et al. 131 and McKenna and Schmidhauser.20' Consequently, the 
more reactive iodotrimethylsilane (TMS-I)13 I'202 was used in the same molar ratio 
(20 eq.), under analogous conditions. This yielded a mixture of two species-, the 
desired product 96 and its ethyl ester 110 in roughly 80 % and 20 % amounts 
respectively. However, when a 25 molar excess of TMS-I was used, and the reaction 
was stirred for 48 hours at 45 °C, 96 was isolated in 95 % yield, as a mixture of 
diastereomers. Once again however, the diastereomeric mixture proved intractable to 
chromatographic separation. 
The biological properties of the erythro and threo diastereomers of the transition-state 
mimic 96 are currently under investigation. 
ME 
Chapter Five 
Conclusions and Suggestions for Future Work 
KII 
The first two intermediates of the known biotin biosynthetic pathway in E. coil have 
been successfully synthesised. Pimeloyl-CoA has been synthesised in 21 % yield by 
the modification of a two-step literature procedure.76 Three alternative approaches 
have been taken in the synthesis of the second known biosynthetic intermediate, 8-
amino-7-oxononanoate (AON). 
A five-step pathway using lJmpolung chemistry, has been used to synthesise (±)-AON 
in 10 % overall yield. (±)-AON synthesised by this pathway has been soaked into 
AONS crystals, and the x-ray structural elucidation of the external PLP-AON 
aldimine bound in the enzyme active site has been achieved 158 
Methodology for the acylation of various aromatic Schiff-bases has been developed, 
and using this approach a three-step synthesis of (±)-AON has been accomplished in 
20 % overall yield. This route should prove applicable to the construction of 
structurally related c-oxoamines. In a modification of this strategy, a three step 
biomimetic synthesis of (±)-AON has been achieved, involving the acylation of a 
deprotonated aromatic aldimine with a thioester, mirroring the hioF-PLP mediated 
process. 
The use of both solid-liquid and liquid-liquid phase transfer catalysis (PTC) in the 
acylation of aromatic Schiff-bases has been investigated. However, further work is 
required to determine whether or not PTC is a feasible alternative to standard 
anhydrous techniques for these systems. 
(±)-AON has also been synthesised by a five step route utilising Dakin-West 
chemistry in an overall yield of 10%. The versatile nature of this pathway, combined 
with the mild conditions employed in the oxazol-5-one acylation step, should make it 
applicable for the synthesis of other biologically important metabolites such as 5-
aminolaevulinic acid and dehydrosphinganine. This route may be also practicable for 
the synthesis of the putative carboxylated AON biosynthetic intermediate 51, and 
similar a-oxo-cx-amino acids. 
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The complimentary nature of the three synthetic approaches to AON developed 
should facilitate the future construction of a wide variety of structurally related 
compounds. 
Dethiobiotin synthetase (DTBS) catalyses the penultimate step in biotin biosynthesis, 
the formation of the ureido ring moiety of dethiobiotin. A phosphonate isostere of 
the putative carbamoyl-phosphate intermediate in this process, identified as a possible 
DTBS inhibitor, has been synthesised in 4.5 % overall yield by a nine step procedure. 
Unfortunately it was not possible to separate the diastereomeric intermediates in the 
later stages of this pathway. Future work would be directed towards choosing an 
alternative N-protection strategy which would facilitate diastereomer separation 
during the synthesis. However the mixture should enable us to demonstrate whether 







All starting materials were purchased from commercial sources (generally Sigma-
Aldrich, Fluka, Fisons and Acros), and were routinely purified by distillation or 
crystallisation before use. Merck (BDH) silica gel 60 (particle size 35 - 60 tim) was 
used for (wet) flash column chromatography. Thin layer chromatography (tic) was 
carried out on aluminium sheets pre-coated with Merck silica gel 60 F254. Solvent 
systems for tic were either diethyl ether / hexane (1:1-4), ethyl acetate / hexane (1:2-
6), dichloromethane / methanol (9:1) or butanol / acetic acid /water (3:1:1). Organic 
extracts were routinely dried over anhydrous sodium sulfate, or magnesium sulfate 
prior to evaporation in vacuo. Melting points were measured on an electrically heated 
Griffin melting point apparatus and are uncorrected. Infra-red spectra were recorded 
on a Biorad FTS7 Fourier Transform infra-red spectrophotometer. Samples were 
prepared as liquid films or as nujol mulls unless otherwise stated. 1H-NMR spectra 
were recorded on a Varian Gemini 2000 (200 MIHz), or a Brucker AX 250 (250 
MHz), a Brucker GSX-1 (270 MHz) or a Varian Unity Inova 600 MIE-Tz instrument. 
The units of chemical shift (6) are given in ppm, and coupling constants (J) are in Hz. 
Mass spectra were obtained by fast atom bombardment (FAB-MS) (with either 
glycerol or thioglycerol as matrices), or by electron impact (E.I.-MS), using a Kratos 
MS 50-TC spectrometer. 
Preparations 




6 	4 	2 
Pimelic acid (6) (3.00 g, 18.8 mmol) was stirred with an excess of thionyl chloride 
(4.0 cm3, 56 mmol) at 60°C for 1 hour with the exclusion of moisture (CaC12 drying 
tube). After evaporation in vacuo the resultant oily material was dissolved in dry 
DCM (5 cm3) and thiophenol (2.0 cm3, 18 mmol) was added dropwise, over 5 mins. 
with stirring at ambient temperature. The reaction was stirred at room temperature 
for 4 hours, then was extracted with a solution of NaHCO3 [3 x 7 cm3, 2 % (w/v)] and 
with water (7 CM)  . The aqueous phases were combined, acidified (pH 1, conc. HCI) 
and extracted with DCM (3 x 10 CM)  . The combined organic layers were dried 
(Na2SO4) then evaporated in vacuo to yield a pale yellow oil which was purified by 
silica-gel chromatography (cyclohexane / ethyl acetate / acetic acid: 15 - 4- 1 by vol.) to 
give 32 as a colourless solid (I.48g, 5.87 mmol, 32%); m.p. 45-46 °C (lit. 76 
46°C), 5H(200 MHz, CDCI3) 1.30-1.45 (2H, in, 4-CH2), 1.52-1.75 (4H, in, 3- and 5-
CH2), 2.30 (2H, t, J 7.2, 2-CH2), 2.60 (2H, t, J 7.3, 6-CH), 7.35 (5H, s, Ar-H), 10.6 
(1H, br 5, CO2f1), o(62.9 MIHz, CDCI3) 22.8, 23.7 and 26.9 (C-3, -4 and -5), 32.4 
(C-2), 41.9 (C-6), 126.5, 127.9, 128.0 and 133.2 (5 x aromatic-C), 178.8 (C-I), 
196.1 (C7), Vmax (nujol, cm') 1710 (CO2 and COS). Found M, 252.08222 (EI-MS), 
C13H1603S requires 252.08202. 
Pimeloyl-Coenzyme A (7) 76 
CoASH, (11 mg, 14 imol) was dissolved in a degassed solution of NaHCO3 [1 cm3, 
2% (w/v)], and 32 (28 mg, 29 jimol) in methanol (0.4 cm) was added. The pH was 
adjusted to 8 (pH paper) by the addition of NaHCO3 [2% (w/v)], and the reaction 
mixture was stirred for 5 hours at ambient temperature, under an atmosphere of 
nitrogen. The pH was then adjusted to 2, by the careful addition of conc. HCI. The 
reaction mixture was washed with DCM (3 x 4 cm3), and concentrated by 
lyophilisation before being purified by HPLC on an Aquapore OD-300 C8 reverse 
phase column, eluting (5 ml/min) with a linear 5%-50% acetonitrile / water gradient 
(0.1% TFA), monitoring at 2 = 214 rim. Thus 7 (8.5 mg, 9.3 .tmo1, 65 %) was 
obtained as a colourless solid ; mlz (MALDI-TOF) 9 10. 0 (Mu-I1 ). 
1-Morpholino-1-cycloheptene (35) 132 
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Cycloheptanone (40.0 g, 350 mmol), morpholine (36.6 g, 420 mmol) and p-toluene 
sulfonic acid (0.40 g) were dissolved in toluene (100 cm'), and heated under reflux (6 
hours), with the water generated being removed by Dean-Stark apparatus. 
Evaporation of the toluene in vacuo gave an yellow oil which was purified by 
distillation under reduced pressure to give 35 as a clear, colourless oil (44.0 g, 238 
mmol, 68%), b.p.140-150 °C/ 20 mm Hg (lit. 132  133-135 'Cl 17 mm Hg), ö (250 
MHz, CDCI3) 1.34-1.46 (4H, m, 4-and 5-Cl-I2), 1.63-1.71 (2H, m,6-CH2), 1.99-2.06 
(211, m, 3-CH2), 2.16-2.20 (2H, m, 7-CH2), 2.65 (4H, t, J 4.8, 8-and ll-CH2), 3.66 






Enamine 35 (8.00g, 44.1 mmol) was added dropwise, with stirring, to a solution of 
acetaldehyde dimethyl acetal (4.50 g, 50.0 mmol) and boron trifluoride etherate (7.48 
g, 52.7 mmol) in dry DCM (50 cm3) at -42°C (dry ice / acetonitrile) under argon. 
After stirring for 3 hours, the reaction mixture was carefully quenched by the addition 
of aq. HC1 (50 cm', 10 mM), and was stirred for a further hour. The organic layer 
was separated and washed with water (50 cm3) and brine (30 cm') before being dried 
(Na2SO4). Evaporation of the solvent in vacuo yielded a dark-brown oil (6.55 g) 
which was purified by silica gel chromatography (hexane / ethyl acetate) to give a 
clear, colourless oil 36 (1.64 g, 9.7 mmol, 22 %) as a mixture of diastereomers 
(formed in a 2:1 ratio), b.p. 80-90 °C / 0.5 mm Hg, Vmax (neat, cm') 1690 (C0), o 
(CDC131  250 MHz) 1.03 (1H, d, J 6.2, 9-CH3), 1.06 (2H, d, J 6.2, 9-CH3), 1.25-1.50 
(4H, m, 4- and 5-CH2), 1.60-1.95 (4H, m, 3- and 6-CH2), 2.30-2.60 (3H, m, 7-CH2 
and 2-CH), 3.21 (2H, s, 10-CH3), 3.22 (1H, s, 10-Cl-I3), 3.59 (1H, m, 8-CH), 6c (62.9 
MHz, CDC13) 15.9 and 16.9 (C-9), 24.3, 24.6, 24.7, 25.5, 25.8, 29.6, 29.7 and 30.4 
(C-3, -4, -5 and 6), 43.8 and 44.1 (C-7), 56.3 and 56.7 (C-b), 57.3 and 58.6 (C-2), 
77.6 and 77.7 (C-8), 215.4 and 216.2 (C-I), Found : M, 170.13104 (EI-MS), 
C10H1802 requires 170.13069. 









Sulfuryl chloride (14.33 g,106 mmol) was added dropwise over 30 mins., with 
stirring, to a solution of ethane-1,2-dithiol (5.00 g, 53.1 mmol) in dry DCM (50 cm) 
at -10 °C under an inert atmosphere. The resultant brown solution was stirred at 0°C 
for a further 30 mins. before ethyl acetoacetate (6.91 g, 53.1 mmol) in DCM (5 cm) 
was added dropwise with stirring at 0-5 °C, over a 1 hour period. The reaction 
mixture was then stirred at room temperature for 5 hours, before being filtered to 
remove a small amount of white polymeric material. After removal of the solvent in 
vacuo, the resultant oil was distilled under reduced pressure yielding a yellow oil 42 
(7.83 g, 35.6 mmol, 67 %); b.p. 145°C / 0.6 mm Hg (lit. 139 125°C I 0.1 mm Hg), 
Vn,ax (neat, cm') 1708 (CO), 1740 (CO2), oH (200 MIHz, CDCI3) 1.30 (3H, t, J 7.2, 8-
CH3), 2.41 (3H, s, 4-CH3), 3.41 (4H, in, 5- and 6-Cl-I2), 4.28 (2H, q, J 7.2, 7-CH2), 
Oc (62.9 MT-Tz,CDCI3) 13.7 (C-8), 25.6 (C-4), 40.1 (C-S and -6), 63.0 (C-7), 76.5 (C-
2), 168.4 (C-i), 197.0 (C-3). Found M, 220.02287 (EI-MS), C8H1203S2 requires 
220.02279. 
2-Acetyl-1,3-dithiolane (38) 139 
A mixture of 42 (3.24 g, 147 mmol), conc. H2SO4 (1.4 cm3), water (5.5 cm) and 
glacial acetic acid (0.7 cm) was stirred and heated under reflux for 24 hours. The 
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mixture was allowed to cool to room temperature before being extracted with DCM 
(3 x 10 CM)  . The combined organic extracts were washed with brine (20 cm) before 
being dried (Na2SO4), and evaporated in VcZCUO to give a brown oil. Distillation under 
reduced pressure afforded 38 as a clear yellow oil (1.78 g, 120 mmol, 82 %); b.p. 
135°C I 0.5 mm Hg (lit. 139  73°C I 0.05 mm Hg), Vnax (neat, cm-') 1717 (CO), öFL 
(200 MHz, CDC13)  2.32 (3H, s, 1-CH3), 3.32 (4H, s, 4- and 5-CH2), 4.84 (IH, s, 3-
CH), 6c (50.28 M1-Iz, CDC13) 24.1 (C- 1), 37.6 (C-4 and -5), 56.4 (C-3), 201.2 (C-2). 
Found M, 148.00 189 (EI-MS), C5H80S2 requires 148.00 166. 
Ethyl 6-iodo hexanoate (43) 140 
6 	4 	2 
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Ethyl 6-bromohexanoate (2.10 g, 1.68 cm3, 9.41 mmol) was added dropwise, with 
stirring, to a solution of anhydrous NaT (2.86g, 19.1 mmol) in acetone (35cm3, freshly 
distilled from CaSO4), with the exclusion of light. The solution was stirred for 1 hour 
then heated under reflux for one further hour. After allowing it to cool, the solution 
was poured into hexane (150 CM),  then filtered through a glass sinter, before the 
solvent was evaporated in vacuo. Removal of the residual solid (filtration) yielded a 
golden oil, which was purified by distillation to give 43 as a clear colourless oil (2.28 
g, 8.75 mmol, 93 %); b.p. 100°C I 5 mm Hg (lit. 140  b.p. 135-137 °C I 16 mm Hg) 
ö (200 MHz, CDC13) 1.25 (3H, t, J 7.2, 8-CH3), 1.45 (2H, m, 4-CH2), 1.65 (21-1, m, 
3-CH2), 1.84 (2H, in, 5-CH2), 2.30 (2H, t, J 7.4, 2-CH2), 3.18 (2H, t, J 7, 6-CH2), 
4.11 (2H, q, J 7.2, 7-Cl-I2), öç' (50.28 MHz, CDC13) 5.2 (C-6), 12.8 (C-8), 22.4, 285, 
31.7 and 32.7 (C-2, -3, -4 and -5), 58.9 (C-7), 172.1 (C-i). Found : M, 270.01168 
(EI-MS), C8H15102 requires 270.01169. 
W. 
Ethyl 7,7-(ethylenedithio)-8-oxo-nonanoate (39) 
0 






Acetyl dithiolane 38 (0.350 g, 2.36 mmol) was added dropwise to a stirred solution of 
LDA [2.71 rnmo!, prepared from diisopropylamine (0.38 cm', 2.71 mmol) and n-
butyllithium (1.25 cm3, 1.94 M in pentane)] in TI-IF (5cm3) at -78°C under argon. 
The red solution was stirred for 1 hour then ethyl 6-iodohexanoate 43 (1.50 g, 5.56 
mmol) in 1-UvIPA (freshly distilled from CaH2) (3.5cm) was added dropwise. The 
reaction was stirred for 4 hours at -78°C, then for 24 hours at room temperature 
before being poured into a stirred solution of saturated ammonium chloride (10 cm 3), 
and extracted with ethyl acetate (4 x 10 CM) . The combined organic layers were 
washed with a saturated aqueous lithium chloride solution (20 cm) (to remove 
HIMPA), then brine (20 cm3), before being dried (Na2SO4). Evaporation of the 
solvent on a rotary evaporator yielded an orange oil (0.70 g), which was purified by 
silica-gel chromatography (ethyl acetate I hexane) to give 39 as a pale yellow oil 
(0.666g. 2.30 mmol, 96%); ö (CDCI3, 200 MHz) 1.24 (314, t, J 7.2, 13-CH3), 1.37 
(4H, m, 4- and 5-CH2), 1.62 (2H, m, 3-CH2), 2.11 (2H, m, 6-CH2), 2.27 (2H, t, J 7.4, 
2-CH2), 2.39 (3H, s, 9-CH3), 3.36 (4H, s, 10- and 11-Cl-I2), 4.09 (2H, q, J 7.2, 12-
CH2), 61 (62.9 MIHz, CDC13) 14.0 (C-13), 25.1 (C-9), 24.4, 26.7 and 28.9 (C-3, -4 
and -5), 33.9 (C-2), 39.2 (C-6), 40.1 (C-10 and -11), 60.0 (C-12), 75.2 (C-7), 173.4 
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Sodium cyanoborohydride (22 mg, 345 imol), 39 (94 mg, 325 imol) and ammonium 
acetate (0.265g, 3.45 mmol, recrystallised from methanol, then vacuum dried) in 
methanol (3 cm) was stirred over 4A molecular sieves for 36 hours under an 
atmosphere of nitrogen. After filtration, the excess methanol was removed in vacuo, 
and HCI (1 M, 10 cm') was added. The mixture was extracted with ether (2 x 10 
cm 3),  then solid NaOH was added to bring the aqueous solution to pH >10. After 
saturation with NaCl, the solution was extracted with ethyl acetate (4 x 10 CM)  . The 
combined ethyl acetate extracts were dried (Na2SO4), and evaporated in vacuo to give 
pure amine 40 as a clear colourless oil (49 mg, 168 l.lmol,  52 
Method 2 
A solution of titanium tetrachloride (0.6 eq., 5.57 mmol, 5.57 cm3, 1M in DCM) was 
added dropwise to a stirred solution of triethylamine (3 eq., 2.81 g, 27.8 mmol), 39 
(2.69 g, 9.28 mmol) and 1,1,1,3,3,3-hexamethyldisila.zane (1.5 eq., 2.25 g, 13.9 
mmol) in dry DCM (70 cm') under an inert atmosphere at room temperature. The 
dark-brown reaction was left overnight, then quenched by the careful addition of a 
solution of NaCNBH3 (3 eq., 1.75 g, 27.8 mmol) in dry methanol (25 CM)  . After 
allowing to react for 30 mins. at room temperature, aq. NaOH was added (50 cm, 
IM), then the phases were separated. The aqueous phase was extracted with a 
further portion of DCM (50 cm3), and the combined DCM layers were evaporated in 
vacuo. The oily residue was then partitioned between ether (30 cm3) and aq. HCI (50 
cm3, 1M), and after separation of the phases, the ethereal layer was extracted with aq. 
HCI (1M, 2 x 25 CM)  . The aqueous layers were combined, the pH was raised to 12 
(NaOH), and NaCl was added until saturation, before it was extracted with ethyl 
acetate (3 x 50 CM)  . The combined organic extracts were dried (Mg504), and 
solvent was removed on a rotary evaporator to yield amine 40 as a clear, colourless 
oil (1.59 g, 5.47 mmol, 59 %) 
oH (CDCI3, 200 MHz) 1.16 (3H, d, J 6.6, 9-CH2), 1.25 (3H, t, J 7.2, 13-CH3), 1.26-
1.42 (2H, m, 4-CH2), 1.56-1.69 (414, m, 5- and 3-CH2), 1.86-1.94 (2H, m, 6-CH2), 
2.30 (2H, t, J 7.5, 2-CH2), 3.06 (1H, q, J 6.6, 8-CH), 3.21-3.25 (414, m, 10- and 11-
CH2), 4.12 (2H, q, J 7.2, 12-CH2), oc  (62.9 MHz, CDC13) 14.2 (C-13),19.5 (C-9), 
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24.8, 25.8 and 29.2 (C-3, -4 and -5), 34.2 (C-2), 40.9 (C-6), 40.2 (C-10 and -Il), 
54.7 (C-8), 60.1 (C-12), 80.2 (C-7), 173.6 (C-i). Found : M, 291.13267 (EI-MS), 
C13H25NO2S2 requires 291.13 161. 
8-(R,S)-Amino-7-oxononanoic acid, (±)-8-AON (Hydrochloride salt) (8) 
H3CCO2U 
A solution of amine 40 (56 mg, 192 mmol) in acetonitrile (0.5 cm) was added 
dropwise to a rapidly stirring solution of N-bromosuccinimide (0. 153 g, 859 mmol) in 
80 % aq. acetonitrile (2 cm') at -5 °C. The orange solution was stirred for 5 minutes 
at -5°C (salt I ice), then stirred whilst slowly allowed to warm to room temperature 
for a further 5 minutes. After quenching with saturated sodium sulfite solution (2 
cm 3), water was added (5 cm'), and the aqueous reaction mixture was extracted with 
ether (2 x 10 CM)  . Evaporation of the ethereal layer in vacuo yielded a yellow oil 
which was immediately added to a solution of acetic acid (2 cm') and conc. HC1 (0.5 
cm 3)  in water (4 CM)  . The reaction mixture was heated under reflux for 18 hours, 
and then after allowing to cool, was extracted with chloroform (3 x 5 cm3). The 
water was removed by lyophilisation to yield a colourless solid which was purified on 
Dowex 50-X cation-exchange resin (H form), eluting with a linear 0-1.5 M HCI 
gradient. Thus 34 was obtained as its colourless hydrochloride salt (21 mg, 93.9 
mmol, 49 %) ; Vmax (nujol, cm') 3134 and 3040 (NH3*  and COOH), 1754 (COOH), 
1727 (CO, ketone), oH  (D20, 200 MHz), 1.13-1.24 (2H, m, 4-CH2), 1.39 (3H, d, J 
7.5, 9-CH3), 1.35-1.53 (4H, m, 3- and 5-CH2), 2.22 (2H, t, J 7.3, 2-CH2), 2.52 (2H, 
in, 6-CH2), 4.10 (1H, q, J 7.5, 8-CH), O (D20, 62.9 MHz) 14.6 (C-9), 22.2, 23.9 and 
27.5 (C-3, -4 and -5), 33.7 (C-2), 37.8 (C-6), 54.8 (C-8), 179.0 (C-i), 209.3 (C-7). 
Found: MIH, 188.12882 (FAB-MS), C9H18NO3 requires 188.12867. 
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To a solution of 41 (108 mg, 370 tmol) in acetone (20 cm) was added Jones' 
reagent (0.45 em', Ca. 4 mmol) over 1 minute whilst stirring at 0°C. After 10 mins. 
stirring at 0°C, the reaction mixture was partitioned between water (20 cm3) and ether 
(20 CM)  . After separation of the phases, the aqueous phase was extracted with a 
further portion of ether (20 CM)  . The combined ethereal extracts were washed with 
Na2CO3 solution (20 cm3, 2% w/v), water (20 cm3) and brine (20 cm') before being 
dried over MgSO4. Evaporation of the solvent in vacuo yielded a brown oil which 
was purified by silica gel chromatography (DCM / ethyl acetate) to give a pale yellow 
oil (60 mg, 186 lImo!, 50%) tentatively assigned as a mixture of cis and trans 
diastereomers of ethyl 8-oxo-7-(1,3 -dithilan- 1 ,3-dioxide)-nonanoate (44); 611 (CDCI3, 
200 MHz) 1.25 (3H, t, J 7.2, 13-CH3), 1.30-1.50 (2H, m, 4-CH2), 1.50-1.75 (4H, m, 
3- and 5-CH2), 2.00-2.30 (2H, 2H, m, 6-CH2), 2.28 (2H, t, J 7.5, 2-CH2), 2.32 (3H, s, 
9-CH3), 3.20-3.40 (3H, m, 10- and I 1-CH2), 3.60-3.75 (1H, m, 10- and I 1-CH2), 
4.11 (2H, q, J 7.2, 12-CH2), Found M, 32.09 176 (EI-MS), C13H2205 S2 requires 
322.09087. 
Benzyl N,N-dibenzyl-L-alaninate (48) 151 
6 	5 
Ph 	N 	Ph 
3 
H3C"'( °.- Ph 
0 
Benzyl bromide (5.99 g, 35.3 mmol) was added to a stirred mixture of L-alanine (1.00 
g, 11.2 mmol) and sodium carbonate (4.74 g, 44.8 mmol) in ethanol (12 cm3) and 
water (12 cm'). The mixture was heated under reflux (90 °C) for 3 hours, then 
allowed to cool to room temperature. Water (20 cm) was added, then the reaction 
mixture was extracted with DCM (3 x 20 CM)  . The combined organic extracts were 
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dried (Na2SO4) and solvent was removed in vacuo to give a yellow oil which was 
purified using silica-gel chromatography (hexane / ether) yielding 48 as a clear, 
colourless oil (3.20 g, 8.91 mmol, 80%); Vmax (neat, cm- ) 1730 (CO), 611 (200 MII-Iz, 
CDCE3) 1.39 (31-i, d, J 7.1, 3-CH2), 3.61 (1H, q, J 7.1, 2-CH), 3.69 and 3.89 (4H, AB 
system, JA13 14.0, 5- and 6-CH2), 5.20 and 5.29 (2H, AB system, J 12.3, 4-CH2), 7.24-
7.48 (15H, m, Ar-H), öc (CDCI3, 62.9 MIHIz) 14.8 (C-3), 54.2(C-5 and -6), 56.0 (C-
2), 65.8 (C-4), 126.7,127.5, 127.6, 128.0, 128.1, 128.2, 128.4, 135.9 and 139.6 (18 x 
Ar-C), 173.3 (C-I), Found : M, 359.18985 (EI-MS), C24H25NO2 requires 
359.18853. 
N,N-Dibenzyl-2-(S)-amino-1-propanol (49) 151 
5 	4 
Ph 	N 	Ph 
3 	 OH 
HO"
; 
N,N-dibenzyl-L-alanine benzyl ester 48 (0.470 g, 1 .3 1 mmol) in dry ether (3 cm) was 
added dropwise to a slurry of LiAIH4 (0.158 g, 4.16 mmol), with cooling (ice bath). 
The reaction was slowly allowed to warm to room temperature, and was stirred for a 
further 4 hours before being carefully quenched by the addition of NaOH (2.5 cm', 
0.5 M). The aluminium salts were removed by filtration and washed with ether, 
before the liquid phases were separated. The organic extract was washed with water 
(5 cm') and brine (5 cm'), before being dried (Na2SO4). Solvent was removed in 
vacuo to give a pale yellow oil, which was purified by silica gel chromatography 
(ether! hexane) to yield 49 as a clear oil (0.280 g, 1.10 mmol, 84%); Vmax (neat, cm') 
3432 (OH), 6H  (200 MII-Iz, CDCI3) 0.98 (3H, d, J 6.6, 3-Cl-I2), 2.99 (1H, m, 2-CH), 
3.12 (1H, br.s, OH), 3.35 and 3.82 (4H, AB system, J 13.2, 4-and 5-CH2), 3.41 (2H, 
m, 1-Cl-I2), 7.2-7.4 (1 OH, m, Ar-H), öc (CDC13, 62.9 MHz) 8.5 (C-3), 52.7 (C-4 and - 
5), 54.0 (C-2), 62.5 (C-i), 127.1 (2 xp-C) 128.3 and 128.8 (8 x o,m-C), 139.1 (2 x 
ipso-C), Found: M, 255.16231 (EI-MS), C17H21N0 requires 255.1623 1. 
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6-Benzyloxybromohexaue (46) 204 
Ph
11_'O~__~~~~B, 
A solution of 1,6-dibromohexane (5.12 g, 20.3 mmol) and NaOBz (2.64 g, 20.3 
mmol) in dry THF (100 cm) was stirred at ambient temperature under an inert 
atmosphere for three days. After evaporation of the solvent, the residue was taken up 
in ether (30 cm3), and washed with aq. HC1 (20 em', 1M), aq. Na2CO3 (20 cm 3, 10 % 
w/v) and brine (20 cm') before being dried (MgSO4). Evaporation of the solvent in 
vacuo yielded a yellow oil which was purified by silica-gel chromatography (hexane / 
ether) to give 46 as a clear, colourless oil (2.01 g, 7.40 mmol, 36 %); 61 (200 MIHz, 
CDC13) 1.39-1.44 (4H, m, 3-and 4-CH2), 1.60-1.67 (2H, m, 5-CH2), 1.83-1.90 (2H, 
m, 2-Cl-I2), 3.40 (2H, q, J 7.2, 6-CH2), 4.47 (2H, q, J 7.0, 1-CH2), 4.50 (2H, s, 7-
Cl-I2), 7.31-7.34 (5H, m, Ar-H), Found : M, 270.06 183 (EI-MS), C13H19BrO (7913r) 
requires 270.06 193. 






Benzophenone imine (1.00 g, 5.52 mmol) and L-alanine-methyl ester hydrochloride 
(0.770 g, 5.52 mmol) in DCM (20 cm') was stirred at room temperature for 24 hours 
with the exclusion of moisture (CaCl2) tube. The reaction mixture was filtered to 
remove NH4C1 and evaporated to dryness on a rotary evaporator. The residue was 
taken up in ether (30 cm') and washed with water (2 x 20 cm') then brine (20 cm'), 
before being dried (MgSO4). Removal of the solvent in vacuo yielded a clear 
colourless oil which slowly crystallised to give the title compound as a colourless solid 
(1.43 g, 96%); m.p. 70-71 °C (lit. 205 m.p. 69-72 °C), 6H (200 MHz, CDC13) 1.41 
(314, d, J 6.8 Hz, 3-CH3), 3.72 (3H, s, 4-CH3), 4.17 (1H, q, J 6.8 Hz, 2-CH), 7.15-
7.65 (10H, m, Ar-H), oc (50.28 M1-Iz, CDC13) 19.4 (C-3), 52.3 (C-2), 60.8 (C-4), 
127.9, 128.1, 128.2, 128.5, 128.5, 128.8, 128.9, 129.0 and 130.5 (10 x Ar-C), 136.4 
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and 139.7 (2 x ipso-C), 169.9 (C-5), 173.6 (C-I), mlz (CI) 268 (MR), 208 [(M-
0O2CH3)], 77 (C6145 ) 
I(Diphenylmethylene)-aminol-acetonitrile (58) 165 
Ph 	 CN 
p:>N 
21 
Prepared analogously to 57 from benzophenone imine (1.00g, 5.52 mmol) and 
aminoacetonitrile hydrochloride (0.510 g, 5.52 mmol) in DCM (20 cm3), to give 58 as 
a colourless solid (1.11 g, 93%); m.p. 82-83°C (lit. 165  m.p. 81-82°C), 6FI(200  MHz, 
CDCI3) 4.22 (2H, s, 2-CH2), 7.1-7.7 (10H, in, Ar-H), öc (50.28 IM[H, CDCI3) 41.5 
(C-2), 117.8 (C-I), 127.4, 128.5, 128.7, 129.1, 129.4 and 129.6(8 x o,m-C), 129.7 
and 13 1.4 (2 x p-C), 13 5. 0 and 138.4 (2 x ipso-C), 174.5 (C-3), m/z (El) 221 (M), 
193 [(M-HCN)], 180 [(M-CH2CN)], 77 (C6H5 ). 
2-(Diphenylmethylene-amino)-propionitrile (59) 172 




58 (3.00 g, 13.6 mmol), Benzyl triethylammonium chloride (BTEAC) (0.310 g, 1.36 
mmol), 50% aqueous sodium hydroxide (3.8 em', 47.6 mmol) and toluene (3 cm) 
were placed in a round-bottomed flask, stoppered and stirred at 0°C for 1 minute. 
Methyl iodide (2.33 g, 16.3 mmol) was added to the reaction mixture via syringe over 
2 hours at 0°C. The reaction was stirred for 2 hours at 0°C, then allowed to warm to 
room temperature and stirred for a further 18 hours. The reaction mixture was 
poured into a separatory funnel containing DCM (40 cm') and water (40 cm3). After 
the separation of the layers, the aqueous phase was extracted with a portion of DCM 
(40 cm3), and the combined organic extracts were washed with water (40 CM),  then 
brine (40 cm3), before being dried over MgSO4. Evaporation of the solvent in vacuo 
yielded an orange oil (3.60 g), which was further purified by column chromatography 
to give the title compound as a yellow oil (2.16 g, 9.23 mmol, 68%); oH (200 MHz, 
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CDC13) 1.55 (3H, d, J 7.0, 3-CH3), 4.32 (1H, q, J 7.0 Hz, 2-CH), 7.20-7.70 (1 OH, m, 
Ar-H), ö (62.9 MHz, CDC13) 20.8 (C-3), 48.0 (C-2), 120.3 (C- 1), 127.1, 128. 1, 
128.8, 128.8 and 128.9(8 x o,m-C) 129.2 and 131.0 (2 xp-C), 134.9 and 138.2 (2 x 
ipso-C), 172.2 (C-4), mlz (El) 234 (M), 207 [(M-HCN)], 77 (C6H5 ). Found: M, 
234.11599, C16H14N2 requires 234.115699. 
Ethyl pimeloyl chloride (60) 206 
0 	 0 
8 
9 
CIJ 0 	CH, 6 	4 	2 
Oxalyl chloroide (1.35 g,10.6 mmol) was added to ethyl hydrogen pimelate (1.00 g, 
5.32 mmol) in a flask fitted with a reflux condenser under nitrogen. The mixture was 
stirred for 45 mins. at room temperature, then for 1 hour at 60°C. Evaporation of 
volatile components in vacuo gave an essentially quantitative yield of 60 as a clear oil, 
which was purified by distillation, b.p. 100-105 °C / 4 mm Hg (lit. 206  b.p. 126-129 
°C / 8.5 mm Hg), ö (200 MHz, CDCI3) 1.25 (3H, t, J 7.2, 9-CH3), 1.32-1.45 (2H, rn, 
4-Cl-I2), 1.57-1.82 (4H, m, 3- and 5-CH2), 2.30 (2H, t, J 7.2, 2-CH2), 2.89 (2H, t, J 
7.3, 6-CH), 4.12 (2H, q, J 7.2, 8-CH2). 
Acetylation of 58 with acetyl chloride 
(All solids were dried and finely ground prior to use) 
Acetyl chloride (75 mg, 955 l.lmol) was added to a dry flask containing 58 (210 mg, 
955 .tmol), potassium carbonate (63 mg, 456 tmol) and BTEAC (12 mg, 53 imol). 
The flask was stoppered then the mixture was sonicated for one hour at 45 °C, before 
being partitioned between water (10 cm3) and DCM (10 cm). After separation of the 
phases, the aqueous phase was extracted with DCM (5 cm'), then the organic layers 
were combined and washed with water (10 cm3), brine (10 cm3) and dried (MgSO4). 
Evaporation of the solvent in vacuo yielded an orange oil which was purified by silica 
gel chromatography (hexane / ethyl acetate) to give a pale yellow oil, tentatively 
assigned as 2-(Diphenylmethylene-amino)-3 -acetoxy-but-2-enonitrile (61), (92 mg, 
306 mol, 32 %); Vmax (neat, cm') 2252 and 2219 (C=N), 1771 (C=O), 6i.1  (68.8 
106 
MHz, CDCI3) 1.90 (1H, br.$), 2.13 (1.5H, s), 2.18 (1.5H, s) and 2.23 (2H,$), 7.3-7.6 
(I OH, m, Ar-H), mlz (El) : 305 (NM'), 245 (M-CH3CO2 ), 219 (M-C4-l602). 
Ethyl 7-IN-methoxy-N-methylamidol-7-oxo-heptanoate  (62) 207 
	
0 	 0 
10 8 H3C. N ' 
	 ' O 	CH, 
H3C° 	
6 	4 	2 
A solution of 60 (1.65 g, 7.99 mmol) in dry chloroform (10 cm) was added to a 
slurry of N,O-dimethyl hydroxylamine hydrochloride (0.790 g, 8.10 mmol) in dry 
chloroform (90 cm) stirring at room temperature under an atmosphere of nitrogen. 
After being cooled to ice/water temperature, neat pyridine (0.13 g, 1.65 mmol) was 
carefully added to the stirring reaction mixture over 10 mins. After the reaction had 
been left stirring for 30 mins at 0°C, it was allowed to warm to room temperature, 
where it was stirred for 12 hours, after a CaCl2 drying tube had been fitted. The 
reaction mixture was then partitioned between ether (30 cm3), and a mixture of 
saturated brine (30 cm3) and water (50 cm) in a separatng funnel. After the layers 
were separated, the organic phase was washed with brine (50 cm') and dried 
(MgSO4), before the solvent was removed by rotary evaporation. The resultant pale 
yellow oil was purified by silica gel chromatography to give 62 as a clear, colourless 
oil (1.64 g, 7.12 mmol, 89 %); 6H (200 MII-Iz, CDCI3) 1.24 (3H, t, J 7.2, 9-CH3), 1.33-
1.44 (2H, m, 4-CH2), 1.60-1.73 (4H, m, 3- and 5-CH2), 2.30 (2H, t, J 7.2, 2-CH2), 
2.43 (2H, t, J7.1, 6-CH2), 3.19 (3H, s, 10-CH3), 3.68 (31-1, s, 11-CH3), 4.12 (2H, q, J 
7.2, 8-CH2), öc (62.9 MHz, CDCI3) 14.0 (C-9), 24.0, 24.5 and 28.6 (C-3, -4 and -5), 
31.4 (C-6), 3 2. 0 (C- 10), 3 4. 0 (C-2), 60.0 (C-8), 6 1. 0 (C- 11), 173.5 (C- 1), 174.2 (C-
7). Found: M, 231.14706 (EI-MS), C11H21N04 requires 231.1470583. 
Methyl hydrogen pimelate (63) 208 
0 	 0 
8 
.,,..CI-13 
HOJ7 	 0 6 	4 	2 
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Freshly distilled thionyl chloride (22.28 g, 190 mmol) was added dropwise, with 
stirring to a flask containing pimelic acid 6 (lOg, 62.4 mmol), which was subsequently 
heated to 50°C and stirred for one hour. The volatile components were removed by 
evaporation in vacuo, then the oily residue was added to a dry flask containing DCM 
(20 CM).  Methanol (1.60 g, 50 mmol) was carefully added over 15 minutes (with 
ice/water cooling). A CaCl2 drying tube was fitted, and the reaction was stirred for 
18 hours at room temperature. After careful quenching by the addition of aq. 
NaHCO3 (20 cm3, 2% w/v), DCM (20 cm) was added and the aqueous and organic 
phases were separated. The organic extract was washed with aq. NaHCO3 (20 cm, 
2% w/v), then brine (10 cm3) before being dried over MgSO4. Evaporation of the 
solvent yielded a pale yellow oil, which was purified by distillation under vacuum to 
give 63 as a clear, colourless oil (13.55 g, 77.9 mmol, 41%); b.p. 95 °C / 0.5 mm Hg 
(lit. 208 b.p. 123 °C / 0.3 mm Hg), oH (200 MHz, CDCI3) 1.34-1.46 (2H, m, 4-CH2), 
1.61-1.73 (4H, m, 3-. and 5-CH2), 2.29 (2H, t, J 7.1, 2-CH2), 2.33 (21-1, t, J 7.2, 6-
CH2) 3.64 (31-1, s, 8-CH3), O (62.9 MHz, CDCI3) 24.4, 24.7 and 28.6 (C-3, -4 and - 
5), 34.0 (C-2 and -6), 51.7 (C-8), 174.3 (C-i), 179.9 (C-7). 




6 	4 	2 	
0 
Prepared as described for 60, from 63 (1.50 g, 8.62 mmol) and oxalyl chloride (2.10 
g, 17.2 mmol) to give 64 as a clear, colourless oil in quantitative yield; b.p. 85 °C / I 
mmHg (lit. 209  b.p. 76-78 °C / 0.3 mmHg), 6H  (200 MHz, CDC13) 1.31-1.46 (2H, m, 
4-CH2), 1.55-1.79 (4H, in, 3- and 5-CH2), 2.31 (2H, t J 7.5, 2-CH2), 2.88 (2H, t, J 




6 	4 	2 
Method 1 
Prepared analogously to 32, from methyl ester 63 (5.00 g, 28.7 mmol), and 
thiophenol (4.82 g, 43.1 mmol) to give 65 as a clear colourless oil (5.57 g, 21.0 
mmol, 73 %), after purification by silica-gel chromatography (hexane / ether). 
Method 2 
Freshly prepared diazomethane (25 mmol in 40 cm' of ether) was added over 15 
minutes to a rapidly stirring solution of thioester 32 (1.05 g, 4.17 mmol) in ethanol 
(45 cm') at 0 °C. The reaction was stirred for 30 minutes at 0°C, then for 18 hours at 
ambient temperature. Evaporation of the solvent in vacuo gave a quantitative yield of 
65 as a clear, colourless oil. 
ö (200 MHz, CDCI3) 1.32-1.47 (2H, in, 4-CH2), 1.56-1.80 (4H, in, 3- and 5-CH2), 
3.32 (2H, t, J 7.3, 2-CH2), 2.66 (2H, t, J 7.4, 6-CH2), 3.67 (3H, s, 8-CH3), 7.40 (5H, 
s, Ar-H), ö( (200 MT-Iz, CDCI3) 23.1, 23.7 and 27.0 (C-3, -4 and -5) 32.4 (C-2), 42.0 
(C-6), 50.1 (C-8), 126.5, 127.8, 128.0 and 133.2 (6 x Ar-C), 172.7 (C-l), 196.0 (C-
7) Found: M, 266.09770 (EI-MS), C14.H1803S requires 266.09767. 
7-10-1  '-oxo-6'-(ethoxycarbonyl)J-8-(benzhydryliderie-amino)-8_cyano_oct-7-
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A solution of 58 (0.395 g, 1.79 mmol) in THE (3 cm3) was added dropwise to a 
solution of LDA {2.05 mmol; prepared from diisopropylamine (0.29 cm', 2.05 mmol) 
and n-butyllithium (1.40 cm3, 1.57 M in hexane)] in THE (4 cm3) at -78°C under 
argon. The deep-red solution was stirred for 1 hour then 60 (0.920 g, 4.78 mmol) in 
THE (2 cm) was added over 15 minutes. The reaction was stirred for 2 hours at - 
78°C, then allowed to warm to ambient temperature over 2-3 hours, where it was 
stirred for a further 18 hours under argon. It was then quenched by the addition of a 
saturated ammonium chloride solution (10 cm'), and after 5 mins. was partitioned 
between water (10 cm') and ether (20 CM)  . After separation, the aqueous phase was 
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extracted with ether (10 cm'), and the combined ethereal layers were washed with 
water (20 cm') and brine (20 cm) before being dried (MgSO4). Evaporation of the 
solvent gave an orange oil which was purified by silica-gel chromatography to yield 
66 as a pale yellow oil (0.250 g, 447 l.lmol, 25 %) Vn,ax (neat, cm') 2192 (CN), 1764 
(C=O), 1732 (OC=O), 1658 (C=N and C=C), oF!  (250 MHz, CDCI3) 1.25 (3H, t, J 
7.2, 11-CH3), 1.26 (3H, t, J 7.2, 20-CH3), 1.30-1.45 (4H, m, 4-and 15-CH2), 1.50-
1.75 (8H, m, 3-, 5-, 14- and 16-CH2), 2.28 (4H, t, J 7.2, 2- and 17-CH2), 2.48 (2H, t, 
J 7.5, 13-CH), 2.80 (2H, t, J 7.2, 6-CH2), 4.12 (2H, q, J 7.2, 10-CH2), 4.12 (2H, q, J 
7.2, 19-CH2), 7.25-7.75 (10H, m, Ar-H), 6(,(62.9 MHz, CDCI3) 14.4 (C-U and 20), 
24.4, 24.7, 24.8, 25.9, 28.6, 28.8, 30.1, 34.0, 34.2, 34.3 and 34.3 (C-2, -3, -4, -5, -6, 
-13, -14, -15, -16 and -17), 60.4 (C-10 and -19), 112.0 (C-8), 115.2 (C-9), 128.4, 
128.7, 128.7, 129.4 and 129.7 (8 x o,m-C), 130.5 and 131.6 (2 x C-p), 135.6 and 
139.0 (2 x C-ipso), 161.7 (C-21), 170.7 (C-7), 171.0 (C-12), 173.7 (C-I and -18), 
mlz 561 (NM), 391 [(M-C9H1403)]. Found: MI-I, 56 1.29723 (CI-MS), C33H41N706 
requires 561.29646. 






Ph 	 %H3 
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A mixture of L-alanine-methyl ester (HCl salt) (5.00 g, 35.8 mmol), benzaldehyde 
(3.80 g, 35.8 mmol), triethylamine (7.25 g, 71.6 mmol) and magnesium sulfate (4.50 
g, anhydrous, oven dried for 24 hours) were stirred at ambient temperature for 18 
hours with the exclusion of moisture (CaC12 drying tube). After filtration, the solution 
was partitioned between ether (100 cm3) and water (150 cm'). The organic layer was 
separated, then washed with water (100 cm3) and brine (100 cm3) before being dried 
(MgSO4). Evaporation of solvent in vacuo gave a yellow oil which was purified by 
silica-gel chromatography (hexane I ethyl acetate) to yield 67 as a pale yellow oil 
(5.65 g, 29.6 mmol, 83 %); OH  (200 MHz, CDCI3) 1.53 (3H, d, J 6.9, 3-CH3), 3.75 
(3H, s, 4-CH3), 4.16 (1H, q, J 6.9, 2-CH), 7.41-7.80 (5H, m, Ar-H), 8.32 (1H, s, 5- 
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CH), 	(50.28 Pvfflz, CDC13) 18.1 (C-3), 50.8 (C-2), 66.6 (C-4), 127.2 127.3 (4 x 
o,m-C), 129.8 (p-Q, 134.4 (ipso-Q, 161.7 (C-5), 171.7 (C-I), mlz (CI) 192 (MB), 
132 [(M-HCO2CH3)], 77 (C6H5). 
(Benzylidene-amino)-acetonitrile (68) 211 
Prepared analogously to 67 from aminoacetonitrile (hydrochloride salt) (2.62 g, 28.0 
mmol), benzaldehyde (3.29 g, 28.0 mmol), triethylamine (5.74 g, 56.6 mmol), 
magnesium sulfate (3.5 g), DCM (50 cm') to give 68 as a colourless solid (3.61 g, 
25.1 mmol, 89 %) m.p. (22-24 °C), ö11 (200 MIHz, CDC13) (mixture of rotamers) 4.65 
(1H 2-CH2), 4.65 (1H, 2-CH2), 7.41-7.80 (5H, m, Ar-H), 8.51 (0.5H, 4-CH), 8.51 
(0.5H, 4-CH), 6c(50.28 MHz, CDC13) 44.2 (C-2), 114.2 (C- 1), 127.3 and 127.5 (4 x 
o,m-C), 130.5 (p-C), 133.5 (ipso-C), 163.4 (C-3). Found: M, 144.06878 (EI-MS), 
C9H8N2 requires 144.06875. 





A solution of 68 (2.40 g, 16.8 mmol) in TI-IF (2.5 cm) was added dropwise to a 
stirred solution of LDA [17.9 mmol; prepared from diisopropylamine (2.50 cm3, 17.9 
mmol) and n-butyllithium (12.8 cm3, 1.46 M in hexane)] in TI-IF (17 cm3) at -78°C 
under argon. The deep-red solution was stirred for 1 hour then methyl iodide (2.38 g, 
16.8 mmol) was added dropwise over 10 minutes. The reaction was stirred for 1 hour 
at -78°C, then for 18 hours at room temperature before being quenched by the 
addition of water (25 CM)  . The mixture was extracted with ether (2 x 40 cm'), then 
the combined ethereal layers washed with water (40 cm3) and brine (40 cm3), before 
being dried (MgSO4). Evaporation of the solvent in vacuo gave an orange oil (2.5 g), 
which was purified by silica-gel chromatography (ethyl acetate / hexane) to yield 69 as 
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a pale yellow oil (1.46 g, 9.24 mmol, 55 %); 6F1  (200 MII-Iz, CDC13) 1.67 (3H, d, J 7.0, 
3-CH3), 4.69 (1 H, dq, J 7.0 and 1. 6, 2-CH), 7.41-7.91 (5H, m, Ar-H), 8.50 (1H, d, J 
1.6, 4-CH), 5c  (50.28 MIT-Iz, CDC13) 19.7 (C-3), 51.8 (C-2), 117.4 (C-I), 127.4 and 
127.7 (4 x o,m-C), 130.4 (p-C), 133.6 (ipso-C), 161.2 (C-4), Found: M', 158.08398 
(EI-MS), C 10H10N2 requires 158.08440. 





Prepared analogously to 62 from acetyl chloride (3.29 g, 41.9 mmol), N,O-dimethyl-
hydroxylamine hydrochloride (4.50 g, 46.1 mmol) and pyridine (7.30 g, 92.3 mmol) in 
chloroform (50 CM),  yielding a yellow oil which was purified by distillation in vacuo 
to give 70 as a clear, colourless oil (3.05 g, 29.6 mmol, 71 %); b.p.35-40 °C / 9 mm 
Hg (lit. 177  b.p. 40-44 °C / 20 mm Hg), Vmax (neat, cm') 1664 (CON), oF!  (200 MHz, 
CDC13) 2.11 (3H, s, 2-CH3), 3.16 (3H, s, 3-CH3), 3.66 (3H, s, 4-CH3), O: (62.9 MHz, 
CDC13) 18.4 (C-2), 30.6 (C-3), 59.7 (C-4), 171.0 (C-i). 




Prepared analogously to 64 from thiophenol (1.07 g, 9.74 mmol), acetyl chloride 
(0.76 g, 9.7 mmol) and triethylamine (1.18 g11. 7 mmol) in DCM (30 cm'), yielding a 
yellow oil which was purified by distillation in vacuo to give 71 as a clear, colourless 
oil (1.08 g, 7.11 mmol, 73 %); b.p.85 °C / 5 mm Hg (lit. 212  b.p. 70 °C / 0.9 mm 
Hg), 0H  (200 MHz, CDC13) 2.43 (3H, s, 2-CH3), 7.42 (5H, s, Ar-H), oc  (62.9 MIFIz, 
CDC13) 29.9 (C-2), 127.7, 128.9, 129.2 and 134.2 (6 x Ar-C), 193.7 (C-i). Found: 
M, 152.02985 (EI-MS), C8H8SO requires 152.02959. 
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12 10 	 CO2CH3 
From the acid chloride 
A solution of the lithium-anion of 67 (prepared by the addition of 67 (0.2.40 g, 1.25 
mmol) to LDA (1.35 mmol) at -78 °C, and stirring for one hour) in THE (10 cm') at 
ca. -50 to -70 °C, was added dropwise to a solution of acid chloride 64 (0.600 g, 3.12 
mmol) in THE (20 cm') at -78 °C, under an inert atmosphere. After 4 hours of 
stirring at -78 °C, the reaction was allowed to slowly warm up to ambient temperature 
over 3 hours, and was stirred for a further 18 hours. Water (30 cm') was added to 
quench the reaction, and after 5 minutes the mixture was extracted with ether (2 x 30 
cm'). The combined ethereal layers were washed with sodium carbonate solution (50 
cm 3, 5 % w/v), water (50 cm3) and brine (30 cm') before being dried (MgSO4). 
Evaporation of the solvent in vacuo gave an orange oil, which was purified by silica-
gel chromatography (hexane / ether) to yield 72 as a pale yellow oil (0. 182g, 525 
imol, 42 %). 
From the thiophenol ester 
Prepared analogously to above from 67 (0.660 g, 2.48 mmol), 65 (200 mg, 1.04 
mmol) to give 72 as a pale yellow oil (62 mg, 177 tmol, 17 %). 
611 (200 MIHz; CDC13) 1.24-1.41 (2H, m, 4-CH2) 1.56 (4H, m, 3- and 5-CH2), 1.60 
(3H, s, 9-CH3), 2.30 (2H, t, J 7.6, 2-Cl-I2), 2.74-2.84 (2H, m, 6-CH2), 3.65 (3H, s, 
11-CH3), 3.76 (3H, s, 12-CH3), 7.28-7.87 (5H, m, Ar-H), 8.23 (IH, s, 13-CH). 
Found: M, 347.17344 (EI-MS), C19H2505N requires 347.17327. 
8-(R,S)-Amino-7-oxononanojc acid (Hydrochloride salt) (8) 
A mixture of 72 (50 mg, 144 p.mol), acetic acid (1 cm) and 4M HC1 (5 cm) was 
stirred at 80 °C for 24 hours. After allowing to cool, water (5 cm) was added, and 
the reaction mixture was extracted with chloroform (3 x 10 cm). Evaporation of the 
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water in vacuo yielded a crystalline material which was purified by ion-exchange 
chromatography (Dowex 50-X (W-form), 0-1.5 M HC1 linear gradient) to afford 34 
as a colourless solid (18 mg, 80 imol, 55 %), which showed identical 
chromatographic properties on tic (Rf = 0.45 (butanol, acetic acid, water, 3: 1: 1, 
visualisation by ninhydrin), and had identical 'H NMR characteristics as a sample 
previously synthesised via an alternative route. 








Alanine (6.00 g, 67.3 mmol) was dissolved in a solution of 0.6 M NaOH (20 cm3) and 
stirred with ice / water cooling. Benzoyl chloride was added until the pH was Ca. 8, 
then 2M NaOH and the remainder of the benzoyl chloride (10.22 g, 72.7 mmol, in 
total) were added in tandem over 1.5 hours, maintaining the pH between 7.8 and 8.5, 
and the temperature between 0 and 5 °C. The reaction mixture was then left for 18 
hours, without stirring at 4 °C for the reaction to proceed to completion. The pH was 
then raised to Ca. 10, and the solution was extracted with ethyl acetate (3 x 50 CM) . 
After lowering the pH to Ca. 2, the cloudy aqueous layer was extracted with ethyl 
acetate (4 x 50 cm'), and the organic extracts were combined, washed with brine (11 x 
100 cm3) and dried (MgSO4) before the solvent was removed in vacuo. The solid 
product was recrystallised (ethanol / water) to give 78 as a colourless solid (10.65 g, 
55.2 mmol, 82 %) ; m.p. 149-151 °C (lit. 192  150-151 °C), 6H  (200 MHz, CDCI3) 
1.60 (3H, d, J 7.2, 3-CH3), 4.85 (1H, dq, J 7.2 and 5.8, 2-CH), 6.81 (114, br.d, J 5.8, 
NH), 7.4-8.1 (5H, in, Ar-H), 6c (50.28 MHz, CDCI3) 17.0 (C-3), 51.1 (C-2), 126.7, 
128.3, 131.7 and 132.9 (6 x Ar-C), 169.5 (C-4), 179.9 (C-i). Found : M, 
193.07425 (EI-MS), C,0H11NO3 requires 193.07389. 
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78 (2.55 g, 13.2 mmol) was added to a stirred mixture of dioxane (30 cm3) and acetic 
anhydride (30 cm3) at 50 °C with the exclusion of water (CaCl2 drying tube). The 
solution was stirred for one hour at 50-60 °C, removed from the heat, then stirred for 
a further 2 hours. Evaporation in vacuo (4 hours) yielded a pale yellow oil which was 
filtered through a plug of silica to give a colourless oil which solidified upon standing, 
yielding 79 as colourless solid (2.19 g, 12.5 mmol, 95%) ; m.p.35-37 °C (lit. 193 
39°C), v 1 (neat, cm') 1823 (CO2), 1651 (C=N), 6ft (200 MHz, CDCI3) 1.58 (3H, d, 
J 7.6, 4'-CH3), 4.45 (1H, q, J 7.6, 4-CH), 7.4-7.8 (5H, in, Ar-H), öc (62.9 MHz, 
CDC13) 16.7 (C-4'), 60.8 (C-4), 125.6 (C-ipso), 127.6 and 128.6 (4 x o,m-C), 132.6 
(C-p), 161.3 (C-2), 178.8 (C-5). 
2-phenyl-4-methyl-5-16-(methoxycarbonyl)-hexyloxyl-oxazole (80) 
Ph 
N~ r4 0 
CH, 
Acid chloride 64 (0.568 g, 2.95 mmol) was added dropwise, over 5 minutes, to a 
solution of oxazolone 79 (0.490 g, 2.80 mmol) and triethylamine (0.283 g, 2.80 
mmol) in TI-IF (7 cm') whilst stirring at 0-5°C under an inert atmosphere. The 
reaction temperature was maintained at ice / water temperature for 3 hours, then was 
allowed to rise to room temperature overnight. After removal of the THF by rotary 
evaporation, the crude product was taken up in ether (20 cm'), and extracted with 
0.3M HC1 (20 cm3) and water (20 cm3), before being dried (MgSO4). Evaporation of 
the solvent in vacuo yielded a yellow oil, which was purified by silica gel 
chromatography (ether / hexane) to give 80 as a clear, colourless oil (0.720 g, 2.17 
mmol, 77%); 611 (200 Mhz, CDCI3) 1.41-1.51 (2H, m, 8'-CH2), 1.60-1.83 (4H, in, 
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7'- and 9'-CH2), 2.10 (3H, s, 4'-CH3), 2.36 (2H, t, J 7.3, 10'-CH2), 2.64 (2H, t, J 7.3, 
6'-CH2), 3.68 (3H, s, 12'-CH3), 7.4-7.9 (5H, m, Ar-H), &. (62.9 MII-Iz, CDC13) 10.2 
(C-4'), 24.0, 24.2 and 28.2 (C-7', -8' and -9'), 33.0 and 33.5 (C-6'and 10'), 51.3 (C-
12'), 120.3 (C-ipso), 125.6 and 128.5 (4 x C-o,m) 127.0 (C-4), 129.9 (C-p), 145.5 
(C-5), 154.7 (C-2), 169.7 (C-5'), 173.7 (C-Ii'), Found : M, 331.14189 (EI-MS), 
C18H21N05 requires 33 1.14197. 
2-phenyl-4-(R,S)-methyl-41-6-(methoxycarbonyl)-hexyloxy]-oxazol-S-one (81) 
Ph 
A solution of oxa.zole 80 (0.194 g, 586 mol) and N,N-dimethy!-4-pyridinarnine 
(DMAP) (9 mg, 73 mol) in TI-IF (3 cm) was stirred at room temperature under an 
inert atmosphere for 10 hours. After removal of the TI-IF in vacuo the crude product 
was taken up in a mixture of ether (10 cm') and 0.1M HCI (10 cm'). The ethereal 
phase was separated and washed with water (10 cm') and brine (10 cm'), then dried 
(MgSO4). Evaporation of the solvent in vacuo yielded a yellow oil which was 
purified by silica gel chromatography (hexane / ether) to give 81 as a pale yellow oil 
(89 mg, 270 imol, 46 %); öu (200 MHz, CDC13) 1.20-1.36 (2H, m, 9CH2), 1.52-
1. 67 
.
.  (4H, m, 8-and 10-CH2), 1.71 (3H, s, 4'-CH3), 2.27 (214, t, J 7.5, 11-CH2), 2.39-
2.77 (2H, m, 7-CH2), 3.64 (3H, s, 13-CH3), 7.44-8.05 (5H, m, Ar-H), Found : M, 
33 1.14177 (EI-MS), C181421N05 requires 33 1.14197 
8-Amino-7-oxononanoic acid (Hydrochloride salt) (8) 
A mixture of oxazolone 81 (20 mg, 60 tmol) and 4M HC1 (3 cm3) was stirred at 80 
°C for 24 hours. After allowing to cool, water (3 cm) was added, and the reaction 
mixture was extracted with chloroform (5 x 6 CM)  . Evaporation of the water in 
vacuo yielded a crystalline material which was purified by ion-exchange 
chromatography (Dowex 50-X (H-form), 0-1.5 M HC1 linear gradient) to afford 34 
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as a colourless solid (5 mg, 22 jimol, 36 %), which showed identical chromatographic 
	
properties on tic (R 	0.45 (butanol, acetic acid, water, 3:1:1, visualisation by 
ninhydrin), and had identical 'H NMR characteristics as a sample previously 
synthesised via an alternative route. 






Sodium borohydride (24 mg, 634 iimoi, freshly purified) was added to a rapidly 
stirring solution of ketone 39 (156 mg, 538 j.imol) in DCM (4 cm') and ethanol 
(4 cm) at 0 °C. After one hour the reaction was quenched by the addition of acetone 
(2 CM),  then the reaction mixture was partitioned between water (25 cm) and ether 
(25 CM)  . The phases were separated and the aqueous layer was extracted with a 
portion of ether (25 cm'). The combined ethereal extracts were washed with brine 
(20 cm), and dried (MgSO4) before being evaporated in vacuo to yield alcohol 41 as 
a clear colourless oil (155 mg, 529 tmol, 98 %); on (200 IVII-Iz, CDC13) 1.24 (3H, t, J 
7.2, 13-Cl-I3), 1.29 (3H, d, J 6.1, 9-CH3), 1.20-1.42 (2H, m, 4-CH2), 1.55-1.73 (4H, 
m, 3- and 5-CH2), 1.70-1.90 (2H, m, 6-CH2), 2.29 (2H, t, J 7.5, 2-CH2), 3.26 (4H, s, 
10- and 11-CH2), 3.87 (1H, q, J 6.1, 8-CH), 4.11 (2H, q, J 7.2, 12-CH2), oc  (50.28 
MHz, CDC13) 12.8 (C-13), 17.1 (C-9), 23.4, 24.5 and 27.9 (C-3, -4 and -5), 32.9 (C-
2), 36.5 (C-6), 38.4 and 38.8 (C-10 and -11), 58.8 (C-12), 72.3 (C-8), 77.3 (C-7), 
173.2 (C-i). Found: MIH, 293.12492 (FAB-MS), C13H2503S2 requires 293.12451. 
Attempted Bromination of 41 





Bromine (82 mg, 513 .imo1) was added over 15 mins to a solution of triphenyl 
phosphine (135 mg, 513 .imol) in DCM (2 cm') stirring at -5 °C under nitrogen. 
After allowing to react for 10 mins., a solution of 41 (150 mg, 513 tmol) and 
triethylamine (52 mg, 513 p.mol) in DCM (3 cm) was added over 30 mins., 
maintaining the temperature between -5 and 0 °C. The reaction was stirred for 1.5 
hours at 0 °C, then for a further 18 hours at room temperature. Ether (4 cm) was 
added, and the resultant precipitate was removed via filtration, with the solid being 
washed with a further portion of ether (4 cm'). The combined ethereal filtrates were 
evaporated in vacuo to give a brown/green oil which was purified using silica gel 
chromatography to yield a pale yellow oil assigned 7,8-(ethylenedithio)-non-7-enoic 
acid ethyl ester (85) (106 mg, 387 imol, 75 %) Vmax (neat) 1731 (C0), 1604 (CC), 
oH (CDC13, 270MHz) 1.25 (3H, t, J 7.2,13-CH3), 1.30-1.42 (214, in, 4-CH2), 1.45-
1.55 (2H, in, 5-CH2), 1.55-1.70 (2H, in, 3-CH2), 1.91 (3H, s, 9-CH3), 2.21 (214, t, J 
7.0, 6-CH2), 2.30 (214, t, J 7.4, 2-CH2), 3.13 (414, s, 10 and ll-CH2), 4.12 (2H, q, J 
7.2, 12-CH2), 6c (CDC13, 68.8 MHz) 14.4 (C-12), 21.0 (C-9), 25.0, 28.6, 28.7, 29.0 
and 29.7 (C-2, -3, -4, -5 and -6), 34.4 and 35.1 (C-10 and -11), 60.4 (C-12), 117.7 
(C-8), 122.6 (C-7), 173.9 (C-I), mlz (El) : 274 (M), 229 [(M-C21450)], 145 [(M-
C7H1302)]. 
Ethyl 8-(R,S)-hydroxy-7-oxononanoate (86) 
OH 
10 
0 	 0 
Prepared analogously to 40 from 41(0. 135g, 462 .tmoI) and NBS (0.410 g, 2.31 
mmoles), to give 86 (the minor product) as a clear, colourless oil (27 mg, 125 .tmol, 
27%); 0H (270 MIHz, CDC13) 1.24 (3H, t, J 7.2, 1l-CH3),1.25-1.4 (2H, in, 4-CH2), 
1.38 (3H, d, J 7.1, 9-CH3), 1.60-1.72 (4H, m, 3- and 5-CH2), 2.30 (2H, t, J 7.4, 2-
CH2), 2.36-2.60 (2H, in, 6-CH2), 4.12 (214, q, J 7.2, 10-CH2), 4.24 (1H, J 7.1, 8-CH), 
Oc (62.9 MHz, CDC13) 14.4 (C-i 1), 20.0 (C-9), 23.3, 24.8 and 28.8 (C-3, -4 and -5), 
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34.2 (C-2). 37.4 (C-6), 60.5 (C-b), 72.8 (C-8), 173.8 (C-i), 212.2 (C-7). Found 








The major product was a clear colourless oil assigned as 8-hydroxy-7-(1,3-dithio!an-
1 ,2-dioxide)-nonanoic acid ethyl ester (mixture of cis and trans diastereomers) (87) 
(101 mg, 314 Ilmol, 68%); 	(neat) 3312 (br., OH), 1726 (C0), 1036 (S-O), oH 
(CDC13, 270MHz) 1.26 (3H, t, J 7.2,13-CH2), 1.35-1.55 (2H, m, 4-CH2), 1.49 (3H, 
d, J 6.2, 9-CH3), 1.55-1.75 (5H, m, 3-, 5- and 6-CH2), 2.00-2.10 (iH, m, 6-CH2), 
2.30 (214, t, J 7.3, 2-CH2), 3.05 (IH, br.s, 8-OH), 3.35-3.45 (21-1, m, 1 1-CH2), 3.70-
3.80 (1H, m, iO-CH2), 3.95-4.02 (1H, m, 10-CH2), 4.12 (2H, q, 12-CH2), 4.50-4.60 
(1H, m), O (CDC13, 68.8 MT-Iz) 14.4 (C-13), 2 1. 0 (C-9), 24.6, 24.7, 24.9, 29.8 and 
34.3 (C-2, -3, -4, -5 and -6), 48.4 (C- 11), 51.7 (C- 10), 60.5 (C-12), 68.0 (C-8), 90.8 
(C-7), 173.9 (C- 1). 	Found MII-I, 325.11488 (FAB-MS), C13H2505S2 requires 
325.11434. 
Ethyl 8-(R,S)-(acetoxy)-7,7-(ethylenedithio)-nonanoate (88) 
0 






Alcohol 41 (500 mg, 1.71 mmol), pyridine (3 cm3) and acetic anhydride (3 cm) in 
DCM (10 cm) were stirred for 18 hours with the exclusion of moisture (CaCl2  drying 
tube). Evaporation of the volatile components in vacuo (3 hours) yielded fairly pure 
acetylated product 88, which was further purified by silica gel chromatography 
(hexane I ether) to give 88 as a clear colourless oil (535 mg,1.60 inmol, 94 %); oF! 
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(200 M1-Tz, CDC13) 1.25 (3H, t, J 7.2, 13-CH3), 1.29 (3H, d, J 6.3, 9-CH3), 1.20-1.45 
(2H, m, 4-CH2), 1.55-1.73 (4H, m, 3- and 5-CH2), 1.80-1.95 (2H, m, 6-CH2), 2.06 
(3H, s, 15-CH3), 2,30 (2H, t, J 7.5, 2-CH), 3.22-3.26 (4H, m, 10- and 1 1-CH2), 4.11 
(2H, q, J 7.2, 12-CH2), 5.13 (1H, q, J 6.3, 8-CH), öc (62.9 MHz, CDC13) 14.1 (C- 
16.5 (C-9), 21.1 (C-IS), 24.7, 25.6 and 29.2 (C-3, -4 and-5), 34.2 (C-2), 38.1 
(C-6), 39.8 and 40.2 (C-10 and -11), 60.1 (C-12), 74.1 (C-8), 77.1 (C-7),170.1 (C- 
173.6 (C-i). Found : M, 334.12632 (EI-MS), C15 H2604S2 requires 334. 12725. 
Ethyl 8-(R,S)-(acetoxy)-7-oxononanoate (89) 
J___' 
13 
6 	 2 	 11 
2 rfl10  
Acetylated compound 88 (140 mg, 419 .tmo1) in acetonitrile (1 cm') was added over 
30 seconds, to a rapidly stirring solution of NIBS (450 mg, 2.52 mmol) in 80 % aq. 
acetonitrile (3 cm') at Ca. -2°C. The bright orange solution was stirred for 10 mins. at 
ca. -2 to 0 °C, then for a further 10 mins. at 0 °C to 10 °C, before being quenched by 
the addition of a saturated solution of sodium sulfite (5 cm'), and partitioned between 
a mixture of ether (20 cm') and water (20 CM)  . After the separation of the phases, 
the aqueous layer was extracted with ether (20 CM),  then the combined ethereal 
layers were washed with water (2 x 20 cm') and brine (20 cm3) before being dried 
(MgSO4). Evaporation of the solvent in vacuo gave an orange oil which was purified 
by silica-gel chromatography (ether / hexane) to yield 89 as a clear colourless oil (96 
mg, 372 imol, 89%); oH  (250 MHz, CDC13) 1.23 (3H, t, J 7.2, 11-CH3), 1.36 (3H, d, 
J 7.1, 9-CH3), 1.27-1.37 (2H, m, 4-CH2), 1.53-1.67 (4H, m, 3-and 5-CH2), 2.11 (3H, 
s, 13-CH3), 2.27 (2H, t, J 7.5, 2-CH2), 2.36-2.55 (211, m, 6-CH2), 4.11 (2H, q, J 7.2, 
10-CH2), 5.05 (1H, q, J 7.1, 8-CH), oc (62.9 MII-[z, CDC13) 14.1 (C-1 1), 16.0 (C-9), 
20.6 (C-13), 22.6, 24.5 and 28.4 (C-3, -4 and -5), 34.0 (C-2), 37.8 (C-6), 60.1 (C-
10), 74.5 (C-8), 170.3 (C-12), 173.5 (C-I), 207.5 (C-7). Found : M, 258.14609 (El-
MS), C13H2205 requires 258. 14673 
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P\ 8 9 
OCI-12CH1 5 
H3C CH,  
Isopropylamine (0.100 g, 1.72 mmol) was added, dropwise over 2 mins., to a solution 
of freshly prepared diethyl phosphonoacetyl-chloride (0.178 g, 832 limol) in dry 
DCM (2 cm'), under nitrogen at room temperature. The reaction was stirred for 5 
hours, then the volatile components were removed in vacuo, to yield a yellow oil. 
Purification using silica-gel chromatography (methanol / chloroform) yielded 106 as a 
clear, colourless oil (155 mg, 653 i.imol, 78 %); oH (200 MHz, CDC13 ) 1.10 (6H, d, J 
6.6, 1- and 3-CH3), 1.28 (6H, t, J 7.1, 7- and 9-CH3), 2.74 (2H, d, J 20.6, 5-CH2), 
4.03 (1 H, heptet, J 6.6, 2-CH), 4.07 (4H, A of ABX, 3Jp11 8.1 and 3J1.1.1 7.1, 6-and 8-
CH2), 6.50 (1H, br.s, NH), O (62.9 MIHz, CDCI3) 16.2 and 16.2 (C-7 and -9), 22.4 
(C-i and -3), 35.0 (C-5, d, 'Jpç 130.0), 41.7 (C-2), 62.5 (C-6 and -8, d, 2Jp(, 6.5), 
162.8 (C-4, d, 2Jpc 3.2), Found: M, 237.11315 (E1-MS), C9H20N0.1P requires 
237.11300 




Ph O )1 ~4 N H 
12 




Triethylamine (30 mg, 296 tmol) was added dropwise to a solution of 40 (46 mg, 
158 tmo1) and benzyl chioroformate (35 mg, 205 tmo1) in DCM (2 cm3) and was 
stirred for 12 hours at room temperature. Ether (10 cm) was added, then the mixture 
was separated from 1M HCI (10 CM), water (10 cm3) and brine (10 cm3), before 
being dried (Na2SO4). Evaporation of the solvent in vacuo left a pale yellow oil 
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which was purified by silica gel chromatography (hexane / ethyl acetate) to give 97 as 
a clear colourless oil (59 mg, 138 mmol, 88%), Vmax (neat, cm-') 341 1 and 3344 (NH), 
1735 (CO2R), 1700 (CON), öi.  (200 MHz, CDC13)  1.19 (314, t, J 7.2, 11-CH3), 1.21 
(3H, d, J 7.0, 9-CH3), 1.32 (2H, m, 4-CH2), 1.63 (4H, m, 5-and 3-CH2), 1.92 (2H, t, 
J 8, 6-CH2), 2.29 (214, t, J 7.4, 2-Cl-I2), 3.31 (4H, s, 10- and 1 1-CH2), 4.12 (1H, in, 8-
CH2), 4.12 (2H, q, J 7.2, 10-CH2), 5.11 (2H, s, 15-CH2), 5.13 (114, m, NT-I), 7.35 
(5H, s, Ar-H), ö (62.9 M}Iz, CDC13)  14.2 (C-13), 19.1 (C-9), 24.7, 25.8 and 29.1 
(C-3, -4 and -5), 34.1 (C-2), 40.0 (C-b), 40.1 (C-1 1), 42.1 (C-6), 53.8 (C-8), 60.1 
(C-12), 66.6 (C-15), 77.1 (C-7), 129.0 and 128.4 (5 x aromatic C), 136.5 (ipso-C), 
155.7 (C-14), 173.6 (C-i), Found: M*,  425.16903 (EI-MS), C21H31NO4S2 requires 
425. 16945. 
Ethyl 7-oxo-8-(R,S)-(N-benzy1oxycarbonyl)-aminoI-nonanoate (98) 
13 
Ph O 12 NH 
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Dithiolane 97 (16 mg, 38 mmol) in acetonitrile (0.4 cm), was added dropwise, with 
stirring, to a solution of N-bromosuccinimide (36 mg, 202 mmol) in 80% aq. 
acetonitrile (0.7 cm3) at -4°C. The red solution was stirred for 7 mins at -4°C, then 
allowed to warm to room temperature over 5 minutes, before being quenched by the 
addition of saturated sodium sulfite solution (1 CM)  . The mixture was extracted with 
ether (3 x 3 cm'), and the combined organic extracts were washed with water (6 cm) 
and brine (6 cm3) before being dried (Na2SO4). Evaporation of solvent in vacuo 
yielded a pale yellow oil (14 mg) which was purified by silica gel chromatography 
(hexane / ethyl acetate), to give 98 as a clear, colourless oil (12 mg, 35 mmol, 94%); 
51 (200 M1I-Iz, CDC13) 1.18 (3H, t, J 7.2, 11-CH3), 1.15-1.30 (2H, m, 4-CH2), 1.28 
(3H, d, J 7.4, 9-CH3), 1.45-1.65 (4H, m, 5- and 3-CH2), 2.22 (2H, t, J 7.5, 2-CH), 
2.43 (2H, m, 6-CH2), 4.05 (2H, q, J 7.2, 10-CH2), 4.30 (1 H, m, 8-CH), 5.03 (2H, s, 
13-CH2), 5.48 (1H, br.s, NH), 7.28 (514, s, Ar-H), öc  (62.9 Mflz, CDC13) 14.1 (C- 
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1.1), 17.8 (C-9), 23.0, 24.5 and 28.4 (C-3, -4 and -5), 33.9 (C-2), 38.7 (C-6), 55.3 (C-
8), 60.1 (C-b), 66.7 (C-13), 127.9, 128.0 and 128.4 (5 x aromatic-C), 136.1 (ipso-
Q, 155.4 (C-U), 173.4 (C-i), 208.8 (C-7), Found : M, 349.18865 (E1-MS), 
C19H27N05 requires 349.18892. 
Ethyl 7-amino-8-(R,S)- [(N-benzyloxycarbonyl)_aminoj-nonanoate (99) 
0 
13 
- 	NH NH2 




The title compound was prepared via the two methods used to synthesise the 
analogous amine 40 and obtained as a mixture of 2-diastereomers, each were 
separable by silica-gel chromatography (DCM / methanol, (a) eluting first) (Yield 
quoted is for total mass of both diastereomers, formed in a 1:1 ratio by both 
methods). 
98(0.171 g, 490 jtmol), ammonium acetate (0.460 g, 6.0 mmol), NaCNBH3 (37 mg, 
0.6 mmol) in methanol (6 CM), stirred for 48 hours at room temperature, yielded (96 
mg, 275 imol, 56 %) of 99 as a clear, colourless oil. 
98 (0.157g, 450 imol), TiC14 (239 tmol, 0.24 cm3 of a IM solution in DCM), 
hexamethyl disilazane (75 mg, 477 limo!) and triethylamine (144 mg, 1.43 mmol) in 
DCM (5 cm) were stirred for 18 hours, then quenched with a solution of NaCNBH3  
(1.43 mmol, 90 mg in 1.5 cm3 of dry methanol). Upon workup as described 
previously, (79 mg, 227 ..tmo1, 51%) of 99 was obtained as a clear, colourless oil. 
Diastereomer (a) : oH (CDCI3, 200 MHz) 1.14 (3H, d, J 6.6, 9-CH3), 1.25 (3H, t, J 
7.2, 1 1-CH3), 1.20-1.50 (6H, m, 3-, 4- and 5-CH2), 1.50-1.70 (214, m, 6-CH2), 2.27 
(2H, t, J 7.5, 2-CH2), 2.72 (1H, m, 7-CH2), 3.66 (114, m, 8-CH2), 4.11 (2H, q, J 7.2, 
10-CH2), 5.09 (2H, s, 13-CH2), 5.18 (1H, br.d, J 8.0, NH), 7.33-7.38 (51J, m, Ar-H), 
Oc (62.9 MHz, CDC13) 14.1 (C-il), 18.7 (C-9), 24.7, 25.8 and 29.0 (C-3, -4 and -5), 
33.9 (C-6), 34.1 (C-2), 50.0 (C-7), 54.7 (C-8), 60.1 (C-iD), 66.4 (C-13), 127.9 and 
128.4 (5xAr-C), 136.6 (C-ipso), 156.1 (C-12), 173.6 (C-i). 
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Diastereorner (b) : ö j (CDC13, 200 MHz), 1.04 (3H, d, J 6.6, 9-CH3), 1.25 (3H, t, J 
7.2, 11-CH3), 1.20-1.50 (4H, m, 3- and 4-CH2), 1.50-1.70 (4H, m, 5-and 6-CH2), 
2.29 (2H, t, J 7.5, 2-CH2), 2.75 (1H, m, 7-CH2), 3.72 (iH, m, 8-CH2), 4.12 (2H, q, J 
7.2, 10-CH2), 5.09 (2H, s, 13-CH2), 5.27 (1H, br.d, J 8.4, NH), 7.33-7.38 (5H, m, 
Ar-H), öc (62.9 M1-[z, CDCI3) 14.1 (C-1 1), 18.7 (C-9) 24.7, 26.0 and 29.6 (C-3, -4 
and -5), 33.9 (C-6) 34.1 (C-2), 50.0 (C-7), 54.8 (C-8), 60.1 (C-b), 66.4 (C-13), 
127.9 and 128.4(5 x Ar-C), 136.6 (C-ipso), 155.8 (C-12), 173.6 (C-i). 
Found : M, 350.220 13 (EI-MS), C19H30N204 requires 350.22056. 
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Method 1 
A solution of amine 99 (18 mg, 50 mmol) in dry DCM (1 em'), was added to a 
solution of DCC (12 mg, 59 mmol) and diethyl phosphonoacetate (11 mg, 55 mmol) 
in dry DCM (1 cm3) at ambient temperature under an inert atmosphere. The reaction 
mixture was stirred for 12 hours and then filtered, with the solid washed with cold 
DCM (2 x 2 CM)  . The filtrate and combined washings were separated from aqueous 
NaOH (0.5 M, 2 CM),  water (2 cm3) and brine (2 cm') then dried (Na2SO4). 
Evaporation of the solvent in vacuo yielded a cloudy yellow oil which was purified by 
silica gel chromatography (DCM / methanol) to give 101 as a colourless oil (9 mg, 17 
mmol, 34 %). 
Method 2 
A solution of diethyl phosphonoacetyl chloride (100) (32 mg, 150 kmol), [freshly 
prepared by the reaction of diethyl phophonoacetate (30 mg, 153 imo1) with oxalyl 
chloride (38 mg, 299 ..tmol)] in DCM (2 CM),  was added to a flask containing a 
solution of amine 99 (20 mg, 57 j.imol) in dry DCM (2 CM), whilst stirring under an 
124 
atmosphere of nitrogen at room temperature. Triethylamine (20 mg, 200 tmol) was 
added over 2 mins., then the reaction was stirred for 24 hours. DCM (5 cm3) and 
NaOH (0.5 M, 7 cm) were added, and after separation of the phases, the organic 
extract was dried (MgSO4). Evaporation of the solvent in vacuo yielded a pale yellow 
oil, which was purified using silica-gel chromatography (DCM / methanol) to give 
101 (mixture of diastereomers) as a colourless oil (21 mg, 40 j.imol, 70 %). 
ö11 (200 MIHz, CDCI3) 1.09 (1.5H, d, J 6.9, 9-CH3), 1.15 (1.5H, d, J 6.9, 9-CH3), 1.21 
(3H, t, J 7.2, I1-CH3), 1.25 (3H, t, J 7.2, 15-CH3), 1.26 (3H, t, J 7.2, 17-CH3),1.10-
1.40 (4H, m, 4-and 5-CH2), 1.40-1.60 (4H, in, 6- and 3-CH2), 2.20 (2H, t, J 7.5, 2-
CH2), 2.70 (1H, d, J 20.6, 13-CH2), 2.78 (IH, d, J 20.6, 13-CH2),3.70-3.90 (2H, m, 
7- and 8-CH2), 4.03 (2H, q, J 7.2, 14-CH3), 4.03 (2H, q, J 7.2, 16-CH3), 4.04 (2H, q, 
J 7.2, 11-CH3), 5.01 (2H, s, 19-CH2), 5.22 (0.5H, br.d, J 8.4, 8-NH), 5.46 (0.5H, 
br.d, J 8.6, 8-NH), 6.51 (0.5H, br.d, J 9.6, 7-NH), 6.60 (0.5H, br.d, J 9.8, 7-NH), 
7.27-7.30 (5H, in, Ar-H), öc (250 MHz, CDC13) 14.1 (C-I 1), 16.1, 16.2 and 16.2 (C-
15 and -17), 14.1 and 18.9 (C-9), 24.7, 25.4, 25.7, 28.7, 29.6 and 31.9 (C-3, -4, -5 
and -6),34.1 (C-2),35.0 (C-13, d, 'Jpc, 137), 35.0 (C-13, d, 125.8), 50.3 and 50.5 (C-
7), 53.4 and 54.1 (C-8), 60.1 (C-b), 62.6 (C-14 and -16, d, 2Jpoc 6.7), 62.7 (C-14 
and -16, d, 2Jpo' 6.5), 66.4 (C-19), 127.8, 127.9, 128.0, 128.3 and 128.3 (5 x Ar-C), 
136.5 (C-ipso), 155.8 and 156.2 (C-18), 164.1 (C-12, d, 2JPC 6.5), 173.6 (C-I). 
Found: MIH, 529.26729 (FAB-MS), C25H42N208P requires 529.26788. 
8-amino-7-phosphonoacctylamidoJ-nonanoic acid (96) 
0 
0 	 II 
P -OH 
	
H2N 	HN 	ii 	OH 
CO2H 
H3C9 	6 	4 	2 
lodo-trimethylsilane (140 mg, 700 iimol) was added dropwise to a solution of 101 
(15 mg, 28 imo1) in dry DCM (3 cm3) at room temperature under argon. The 
reaction was stirred at 45 °C for 48 hours before being quenched by the addition of 
water (10 cm') and chloroform (5 CM) . After the separation of the layers, the 
aqueous phase was extracted repeatedly with chloroform (7 x 15 CM)  . Lyophilisation 
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afforded 96 (mixture of diastereomers a and b) as a pale brown solid (8.5 mg, 26 
p.mol, 95 %),-6H (250 MHz, D20) 1.20 (1.5H, d, J 6.8, 9bCH3), 1.29 (1.5H, d, J 6.7, 
9aCH3), 1.20-1.50 (4H, m, 4- and 5-CH2), 1.50-1.70 (4H, m, 3- and 6-CH2), 2.34 
(2H, t, J 7.3, 2-CH2), 2.78, 2.79, 2.80, 2.81, 2.87, 2.88, 2.88 and 2.89 (2H, AB of 
ABX, I 1-CH2), 3.32 (0.5H, br. dq 6.6 and 3.2, 8a-CH2), 3.49 (0.5H, hr. dq J 6.6 and 
3.7, 8-CH2), 3.88 (0.5H, dt J 6.6 and 3.7, 7a-CH), 4.11 (0.514, hr. dt J 3.5 and 6.5, 
7h-CH), 5c (62.9 MHz, D20) 11.8 and 15.0 (C-9), 24.0, 24.3, 24.8, 27.6 (C-3, -4 and 
-5), 29.1 and 29.7 (C-6), 33.6 (C-2), 37.2 (C-il, d, 1Jpc 125), 37.4 (C-lI, d, 'JPC 
124), 51.2 (C-7), 51.6 and 52.2 (C-8), 170.1 (C-b, d, 2j  p(- 4), 179.1 (C- 1), op (1320, 
101.26 MHz) 17.74 (hr. s). Found M, 310.12967 (FAB-MS), C11H23N206P 
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Introduction 
In Nature, the a-amino acids serve not only as building blocks for the synthesis of 
proteins but also as starting materials for syntheses of a bewildering number of other 
important products. Dissection of these pathways has been rewarded not only by an 
intimate understanding of the mechanisms of biosynthetic processes but also by 
discovery of new chemistry. In this context, it has been recognised for many years that 
the biosynthesis of almost all the B vitamins start from amino acid precursors and 
involve quite unique chemistry. However, despite their importance and their ubiquitous 
presence in Nature, the fact that vitamins are produced in minute quantities, by enzymes 
present in barely detectable amounts, has seriously limited the study of these reactions. 
Over the past five years, however, the application of the techniques of molecular biology 
to this field has led to rapid progress. Biotin biosynthesis is a typical case. 
Biotin 5, the cofactor of almost all carboxylase and transcarboxylase enzymes, is a 
commercially important compound used not only as a vitamin in food supplements but 
also, in view of its ability to make tight complexes with avidin and streptavidin, as a 
probe in molecular and cell biology. Because biotin is found in only miniscule amounts 
in producing organisms, all commercially used biotin is currently obtained by total 
synthesis. More than fifteen syntheses of biotin have been published in the last four 
decades. Although the commercial chemical synthesis has been reduced now to only 
twelve steps - biotin producing organisms can effect the efficient synthesis of biotin from 
L-alanine and pimelic acid in only five reactions (Scheme 1) - suggesting that we might 
still have a little chemistry to learn from Nature. 
The route shown in Scheme 1 was determined by early work by Campbell and by 
Eisenberg and appears to be ubiquitous in Nature [1]. Each of the reactions shown are 
enzymatically unusual: Step (i) has a few parallels - one notably being the first step in 
vitamin B12  synthesis catalysed by 5-aminolevulinic acid synthase; Step (ii) is a trans-
amination - but is unique in requiring 5-adenosylmethionine as the nitrogen donor; Step 
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Scheme 1. The biotin pathway. 
I 0_U IUF II IIlUJCIflI 9U1 III.. OL.ILI 
CO2 	 ATP 
bioD 




(iii) is unique, here CO2, and not HC011  is involved and the ring closure involves only 
one activation step for formation of two C-N bonds. The final step (iv) is chemically the 
most intriguing; involving the introduction of sulfur at two apparently chemically 
unreactive sites to form a tetrahydrothiophene ring. Recent work on the enzymes of 
biotin biosynthesis in Edinburgh, and elsewhere, has led to not only to insight into the 
details of the reactions involved but also to the development of enzymatic and 
biomimetic chemical routes to the immediate precursor of biotin. 
Results and Discussion 
At the start this work, we were confronted by a problem - the production of the E. coli 
enzymes is controlled at the genetic level by feedback inhibition mediated by binding of 
the biotin holoenzyme/biotin-AMP anhydride complex to the operator region of the 
biotin operon [2]. Thus we had first to subclone all of the genes in the operon and 
express each of these individually. This was non-trivial, complicated by the lack of 
convenient restriction sites and the overlap of some of the gene reading frames. Two of 
the individual genes (bioB and bioF) proved extremely difficult to overexpress - but now 
all of these enzymes are routinely available in 20mg/L amounts. The second problem 
was the non-availability of intermediates. Syntheses of diaminopelargonate 3 (from 
dethiobiotin) and pimeloyl CoA 1 proved straightforward - but that of novel ketoamino 











Scheme 2. Synthesis of (±)ketoaminopelargoniC acid 2. 
A combination of chemical and biological techniques has allowed us to examine each 
step in the pathway in detail. Exemplative of this work is the study of the penultimate 
30 
Syntheses of a Vitamin from L-Alanine 
enzyme, dethiobiotin synthetase. This catalyses the third step in the pathway - the 
formation of the ureido ring of 4 by dethiobiotin synthetase. Superficially, this reaction 
seems quite straightforward but the fact that the enzyme uses CO2 and only a single ATP 
- ADP + P turnover poses a problem. How can two N-C bonds be formed with only a 
single activation step? The answer has emerged from a combination of chemical, kinetic 
and crystallographic studies from the group in Edinburgh, and also from work in Upsala 
and Delaware [3]. The first problem was to determine the order of substrate addition 
and we found that 3 and 14CO,  were combined enzymatically, in the absence of ATP, to 
give an unstable DAPA carbamate. The next step was shown by 'O labelling to involve 
formation of a phosphoric acid anhydride species which undergoes attack by the 
neighbouring amino group to give the product 4 [3a-c] (Scheme 3). The structural 
criteria which are important in the series of reactions catalysed by the enzyme has now 
been revealed by crystallographic and kinetic studies using synthetic substrates and 
intermediate mimics. Substitution of the terminal methyl group of 3 with either H or Et 
results a 10 fold lowering of enzymatic efficiency indicating that methyl group binding 
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Scheme 3. The role of methyl group binding in the ureido ring closure reaction. 
Crystallography has also revealed that the conversion of DAPA carbamate 3a to DTB 
4 by the enzyme involves a change in conformation of the Me group. This can be 
rationalised in that the ureido ring closure step requires a ca 600  rotation round the C7-C 
bond of the phosphate-carbamate mixed anhydride to effect an effective angle of attack 
of the 8-amino group for ring closure which places the Me group in a new binding 
pocket in the protein architecture. This rotation is optimised for methyl group 
interaction with the hydrophobic regions of the reaction sites in the protein skeleton. 
Studies on the mechanisms of the earlier enzymes of the pathway in Edinburgh and 
Paris [4] have augmented our knowledge and with adequate amounts of the enzymes in 
hand we have now been able to complete a catalytic ex vivo synthesis of dethiobiotin 
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from L-alanine. For most biochemical pathways just adding starting materials to an 
enzyme mixture can result in an equilibrium state with no significant final product 
formation. However here, as in the B12 studies of Scott and his coworkers [5], the 
enzymatic machinery works in our favour. Since the KM'S of each of the enzymes are 
extremely low, dethiobiotin can be produced in virtually quantitative yield from 
L-alanine and pimeloyl CoA by enzymic catalysis in vitro [Steps (i) to (iii), Scheme 1]. 
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Scheme 4. A hiomimetic synthesis of (±) dethiobiotin 4. 
What we have learned from the biosynthesis has also been applied to designing a 
biomimetic synthesis of (±)dethiobiotin (Scheme 4). However completion of the 
pathway requires in vitro biochemical or chemical realisation of the final step - the 
introduction of a sulfur atom between C-6 and C-9 of the dethiobiotin skeleton to form 
the final tetrathiophene ring (Scheme I). We know now that 9-mercaptodethiobiotin is a 
probable intermediate and that this conversion is a complex S-adenosylmethionine 
initiated radical process, requiring not only the dimeric [2Fe-2S] biotin synthase protein, 
flavodoxin and flavodoxin reductase, but also a nijS-type cysteine desulfurase [6]. The 
current biological chemistry challenge is to determine the mechanism of the enzyme 
system - and the future chemical challenge will be to design a synthetic reaction which 
will be able to mimic the efficiency of the biological process. 
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